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ABSTRACT 
Femoral neck fracture (FNF) in elderly patients is a common cause of suffering and 
premature death in individuals with osteoporotic bones. This fracture type is more common in 
women after menopause, and the associated patients are often osteoporotic, which contributes 
to a higher incidence of fractures. FNFs can be undisplaced or displaced, with the latter 
representing 70-75% of cases. The treatment of displaced FNF in the elderly is still 
controversial. Optimizing the treatment for improved outcomes and reducing the need for 
secondary surgery are mandatory for humanitarian and economic reasons. Various options for 
the surgical treatment of patients with FNF are available, including internal fixation (IF), 
hemiarthroplasty (HA) and total hip arthroplasty (THA). Each treatment has its advantages 
and disadvantages. IF is not controversial for the treatment of undisplaced FNF and 
represents the method of choice for displaced FNF in young patients (less than 65-70 years 
old) and the frailest elderly patients who are not medically fit for prosthesis surgery. HA is 
the most common surgical procedure in elderly patients with low functional demands, 
whereas THA is the preferred method for healthy, active and lucid elderly patients. HA is still 
the dominant procedure for the treatment of displaced FNF. In Sweden, 64% of all patients 
with displaced FNF are treated with HA, 22% are treated with THA and 14% are treated with 
internal fixation. The most common method of performing prosthesis fixation in elderly 
patients is with bone cement, although concerns over performing this method in older frail 
patients with multiple comorbidities have been noted. Bone cement implantation syndrome 
(BCIS) is more prevalent in cemented stems than uncemented stems in patients with FNF. 
Severe BCIS has a substantial impact on early and late mortality. Thus, the use of 
uncemented hydroxyapatite stems for this patient group may be justified. Recent reports on 
modern hydroxyapatite-coated femoral stems used in FNF patients have shown promising 
early results. However, a more direct comparison between uncemented and cemented stems 
is required because recent register data suggest a significant increased risk of reoperation with 
uncemented stems. The functional outcome and the rate of complications and reoperation 
after modern HA in patients with displaced FNF in combination with cognitive dysfunction 
are relatively unknown. This patient group has not been sufficiently analysed, and a few 
studies have recommended IF for this patient group. Moreover, some studies have reported 
improved post-operative functional outcomes and a lower rate of complications and 
reoperation after cemented HA compared to IF, even in the presence of severe cognitive 
dysfunction.  
The aim of this thesis was to define the optimal treatment for elderly patients with a displaced 
FNF with respect to their age, functional demands and cognitive function. 
Study I: This study is a randomized controlled trial (RCT) of 100 patients ≥65 years of age 
with a displaced FNF, and it was designed to compare THA and IF. Follow-up evaluations 
were performed at three months and at one, two, four, eleven, and seventeen years. We 
found a higher Harris hip score and a lower rate of reoperations for patients who were treated 
with THA. 
Study II: This study is a RCT of 69 patients aged 65-79 years with a displaced FNF, and it 
was designed to compare uncemented and cemented stems in patients treated with THA. The 
patients were followed up at three months and one and two years. Patients who were treated 
with the uncemented stems showed more complications than patients who were treated with 
the cemented stems without affecting the functional outcome. 
Study III: This study is a RCT of 120 patients ≥80 years of age with a displaced FNF, and it 
was designed to compare THA and HA. The one-year results showed that THA did not 
present superior outcomes to those of HA. 
Study IV: This study is a prospective observational cohort study of 160 patients with 
displaced FNFs, and it was designed to compare the results after HA in 100 patients aged ≥65 
years with cognitive dysfunction with that of 60 patients aged ≥80 years without cognitive 
dysfunction. The patients were followed up at three months and one year. HA in patients with 
cognitive dysfunction was associated with higher mortality and a higher prevalence of the 
inability to walk. Patients with cognitive dysfunction who did not receive geriatric 
rehabilitation had worse patient-reported outcomes and were almost 9-times more likely to be 
confined to a wheelchair or bedridden. 
The main conclusions of this thesis are as follows:  
• THA is the treatment of choice for a displaced FNF in healthy and lucid elderly 
patients with good hip function preoperatively. 
• Uncemented femoral stems should be avoided in patients older than 65 years with a 
displaced FNF. 
• THA yields no benefits over HA in octa- and nonagenarians treated for a displaced 
FNF. 
• HA is a safe option as a treatment for displaced FNF in patients with dementia or 
cognitive dysfunction. 
  
   
 
 
SAMMANFATTNING (SUMMARY IN SWEDISH) 
Lårbenshalsfrakturer hos äldre patienter är en vanlig orsak till lidande och för tidig död i en 
åldrande befolkning med osteoporotiskt ben. Denna fraktur är vanligare hos kvinnor efter 
klimakteriet och patienterna är ofta osteoporotiska vilket kan bidra till en högre 
frakturförekomst. Lårbenshalsfrakturer kan vara med eller utan felställning, den förra är 
vanligast (70-75%). Behandlingen av felställda lårbenshalsfrakturer hos äldre är fortfarande 
kontroversiell. En optimering av behandlingen i syfte att minska behovet av sekundär kirurgi 
och erhålla ett bättre slutresultat är nödvändig både ur humanitära och ekonomiska skäl. 
Olika alternativ för kirurgisk behandling är tillgängliga, d.v.s. intern fixation, halvprotes och 
total höftprotes. Varje behandling har sina för- och nackdelar. 
Intern fixation är okontroversiell vid behandling av icke felställda lårbenshalsfrakturer och är 
en standard metod för behandling hos unga patienter (under 65-70 år) och hos fragila äldre 
patienter som inte är medicinskt lämpade för protesoperation. Halvprotes är ett vanligt 
kirurgiskt ingrepp hos äldre över 80 år med låga funktionella krav, medan den totala 
höftprotesen är den föredragna metoden för en aktiv och klar patient under 80 år. Behandling 
med halvprotes är den dominerande proceduren för behandlingen av dessa frakturer. I 
Sverige behandlas 64% av patienterna med felställda lårbenshalsfrakturer med halvprotes, 
22% med total höftprotes och 14% med intern fixation. Bencement är den vanligaste 
fixationsmetoden av proteskomponenter. Användandet av bencement hos äldre fragila 
patienter med multipla comorbiditeter innebär en ökad risk för tromboemoboliska 
komplikationer vilket kan leda till tidig död. Detta kan motivera användandet av 
ocementerade stammar i denna patientgrupp. Nya rapporter om moderna, 
hydroxapatitbelagda lårbenstammar som används hos patienter med lårbenshalsfrakturer har 
visat lovande tidiga resultat. Emellertid har nya registerdata visat en ökad risk för protesnära 
fraktur och därför krävs en direkt jämförelse mellan ocementerade och cementerade stammar. 
Det funktionella utfallet och förekomsten av komplikationer hos patienter med felställda 
lårbenshalsfrakturer i kombination med kognitiv dysfunktion som behandlas med en modern 
halvprotes är relativt okänt. Dessa patienter har hög mortalitet efter en höftfraktur och låga 
funktionella krav samt en låg hälsorelaterad livskvalitet före frakturen jämfört med patienter 
utan kognitiv dysfunktion. Därför har intern fixation rekommenderats för denna patientgrupp. 
Å andra sidan finns rapporter vilka beskriver bättre postoperativ gångförmåga och 
funktionellt resultat efter halvprotes i närvaro av allvarlig kognitiv dysfunktion. 
Syftet med denna avhandling var att definiera den optimala behandlingen för äldre patienter 
med felställd lårbenshalsfraktur med avseende på ålder, funktionella krav och kognitiv 
funktion. 
Studie I: Detta är en RCT av 100 patienter ≥ 65 år med felställda lårbenshalsfrakturer som 
jämför total höftprotes och intern fixation. Uppföljningen utfördes på tre månader och 1, 2, 
4, 11 och 17 år. Vi hittade högre Harris hip score och mindre omoperationer för patienter 
som behandlades med total höftprotes. 
Studie II: Detta är en RCT av 69 patienter 65-79 år med felställda lårbenshalsfrakturer som 
jämför ocementerade och cementerade stammar i total höftprotes. Patienterna följdes upp 
vid 3, 12 och 24 månader. Den ocementerade stammen visade mer komplikationer än 
cementerad stam utan att påverka funktionella resultaten. 
Studie III: Detta är en RCT av 120 patienter ≥80 år med felställda lårbenshalsfrakturer 
som jämför total höftprotes med halvprotes. 1 års resultat visar inget överlägset resultat vid 
utförande av total höftprotes över halvprotes. 
Studie IV: Det här är en prospektiv observations kohortstudie av 160 patienter med 
felställda lårbenshalsfrakturer, jämför halvprotes hos100 patienter ≥ 65 år med kognitiv 
dysfunktion and hos 60 patienter ≥ 80år utan kognitiv dysfunktion. Patienterna följdes upp 
vid 3 och 12 månader. Halvprotes hos dementa och/eller patienter med kognitiv 
dysfunktion associeras med högre mortalitet och högre förekomst att bli icke gångare utan 
att påverka höftrelaterade komplikationer, reoperationer, hälsorelaterad livskvalitet och 
höftfunktion. De patienter med kognitiv dysfunktion som inte fick geriatrisk rehabilitering 
hade sämre patientrapporterade utfall och var nästan 9 gånger mer benägna att vara 
begränsade till rullstol eller sängliggande. 
De huvudsakliga slutsatserna i denna avhandling är följande: 
• Total höftprotes är den bästa behandlingen för en felställd lårbenshalsfraktur hos friska 
och kognitivt klara äldre patienter med god höftfunktion innan frakturen. 
• Ocementerad stam bör undvikas hos patienter äldre än 65 år med en felställd 
lårbenshalsfraktur. 
• Total höftprotes ger inga fördelar över halvprotes hos äldre äldre patienter behandlades 
för en felställd lårbenshalsfraktur. 
• Halvprotes är ett säkert alternativ för behandling av felställda lårbenshalsfrakturer hos 
patienter med demens eller kognitiv dysfunktion  
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INTRODUCTION 
HISTORICAL BACKGROUND 
Hip fractures affect the upper quarter of the femur and can involve the neck, trochanteric and 
subtrochanteric regions. Femoral neck fractures (FNFs) constitute approximately 50% of all 
hip fractures, and approximately 75% of all FNFs are displaced. Sir Astley Cooper (1768-
1841) first described FNFs in 1822. Conservative treatment with bed rest or a spica-cast for 
abduction and internal rotation [1] represented the most common methods for many years. 
The first osteosynthesis is attributed to the German surgeon Von Langenbeck (1810-1887), 
who nailed a non-united FNF with a metal silver screw in 1858. However, the patient died 
because of infection. Loreta reported the first successful attempt of this procedure in 1888. In 
1883, the American surgeon Nicholass Senn suggested that all FNFs should be treated 
surgically, although the proposition was not extensively accepted. Many sporadic attempts 
with limited success [2] were conducted with open reduction and temporary external or 
internal fixation until Smith-Petersen introduced the three-flanged nail in 1931 at the 
beginning of the era of internal fixation. The design was improved by the Swedish surgeon 
Sven Johansson (1932) and the American H. Heyward Wescott (1934). In 1941, the 
American Academy of Orthopedic Surgeons (AAOS) advocated the trifin nail technique for 
internal fixation. However, in 1976, the British Medical Research Council indicated that the 
trifin nail was not suitable for displaced FNFs. Asnis cannulated screws were developed in 
1980, and they are still in use today.  
In Sweden, Sven Johansson was the first person to improve the surgical technique for FNFs 
when he designed and used a nail to stabilize the fracture in 1932. In 1964, Nils Rydell at 
Sahlgrenska University Hospital designed a new spring-loaded nail with four flanges to 
prevent slipping after surgery. The Rydell nail predominated until Lars Ingvar Hansson 
introduced the hook pin, later called the Hansson pin, in 1982. In 1980, another orthopaedic 
surgeon named Sven Olerud invented the Olmed screw, which is currently the most used 
screw for FNFs in Sweden. 
Despite the improvement in osteosynthesis, healing complication rates have been high; 
therefore, primary hip arthroplasty has been considered an alternative treatment. 
Endoprosthetic replacement has been used since the 1940s (Moore 1943). Originally only 
hemiarthroplasty (HA) was performed, although total hip arthroplasty (THA) was 
subsequently introduced as a primary treatment. 
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EPIDEMIOLOGY 
The estimated number of hip fractures worldwide is expected to rise to 1.7 million by 2025 
and to 6.2 million by 2050 [3, 4]. The incidence of hip fractures is variable in different 
regions of the world. Scandinavian countries and the U.S. have been categorized as having a 
very high risk based on ten-year probabilities, whereas countries such as Turkey, Korea, 
Venezuela and Chile have been categorized a low-risk countries [5]. Improved osteoporosis 
prevention, healthier elderly populations, increased body mass index (BMI), improved 
functional ability and several fall preventive measures may have contributed to the decrease 
in the age-adjusted incidence of hip fractures [6-9]. The increase in the number of hip 
fractures despite the decrease in age-adjusted incidence is related to a growing ageing 
population worldwide, especially in the West. FNF in elderly patients is a common cause of 
suffering and premature death in individuals with osteoporotic bones. This type of fracture is 
more common in women after menopause, who are often osteoporotic, which contributes to a 
higher incidence of fractures. The mean age of hip fracture patients is approximately 80 
years, and an exponential increase in incidence is observed with age [10, 11]. The incidence 
of hip fractures in Sweden is 18000 annually, which is expected to increase to 30,000 in 2050 
as predicted by Rosengren et al. [12]. Sweden has one of the highest incidences of hip 
fractures worldwide [13], with 22 (men) and 34 (women) annual cases per 1000 persons aged 
80 years and over as measured for 2013 [14]. The lifetime risk of hip fracture in Sweden is 
11% for men and 20% for women [11]. Patients with hip fracture present a doubled risk of 
death during the first year compared with age-matched controls [15]. Risk factors associated 
with higher mortality are the American Society of Anesthesiologists (ASA) score, cognitive 
dysfunction and male gender [16, 17]. In particular, patients with a severe or incapacitating 
disease (ASA 3 – 4) combined with severe cognitive impairment (short portable mental status 
questionnaire (SPMSQ) 0 –2) have a higher mortality rate [17]. Other factors, such as a 
prolonged waiting time for surgery and a short length of stay in the hospital, have been 
suggested as risk factors [18-20] 
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CLASSIFICATION 
Although several classification systems are available for FNFs, none has been shown to be 
practical or have satisfactory and accurate predictive value. The first biomechanical 
classification was Pauwels’ classification (1935), which is still frequently used in the 
literature and calculates the angle between the fracture line of the distal fragment and the 
horizontal line to determine the shearing stress and compressive force. Investigations of the 
reliability of Pauwels’ classification [21, 22] have shown low interobserver agreement, thus 
demonstrating the unreliability of this classification. The AO (Arbeitsgemeinschaft für 
Osteosynthesefragen) classification has been difficult to use in practice and has shown low 
intraobserver and interobserver reliability [23]. The most commonly used classification 
method is likely that of Garden (1961), which consists of four groups and utilizes the 
degree of displacement or impaction as a discriminator. The Garden and AO classifications 
are more reliable than Pauwels’ classification [24]. However, the reliability of the four-
grade Garden classification shows poor reliability because of the difficult radiological 
distinction between different grades, especially I and II, and limited clinical relevance in 
terms of predicting the likelihood of mal-unions or avascular necrosis [25-32]. Several 
authors have recommended a simplified classification that divides FNFs into non-displaced 
and displaced fractures [28-32]. The reliability of the Garden classification improves when 
only the term non-displaced or displaced FNF is used [33]. Figure 1 shows the Garden 
classification.  
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Figure 1: Classification of femoral neck fracture according to Garden 
 
 
TREATMENT OF FEMORAL NECK FRACTURE 
The femoral head acquires its blood supply from three sources: (1) intramedullary vessels in 
the femoral neck, (2) ascending cervical vessels in the capsular retinaculum, and (3) round 
ligament vessels. The intramedullary supply is always interrupted by the fracture, and 
retinaculum vessels may also be disrupted if considerable displacement is observed. In 
elderly people, the remaining supply in the ligamentum teres is at best fairly meagre and non-
existent in certain patients. Hence, a high incidence of avascular necrosis is observed in 
displaced FNFs. FNFs are, by definition, intracapsular, and they present a poor capacity for 
healing because (1) the injury deprives the head of its main supply by disruption of the 
capsular vessels; (2) intra-articular bone has only a flimsy periosteum and no contact with 
soft tissues, which could promote callus formation; and (3) synovial fluid prevents clotting of 
the fracture haematoma. Accurate apposition and impaction of bone fragments with closed or 
open reduction and internal fixation therefore present increased importance for fracture 
  5 
healing. Operative treatment is almost mandatory. Displaced FNFs will not unite without 
internal fixation.  
Non-surgical treatment 
Non-surgical treatment of FNF is rarely performed, although it may be considered in frail or 
moribund patients for whom the risk of surgical intervention outweighs the benefit. 
Surgical treatment  
The choice of surgical procedure in elderly patients with FNFs is influenced by many 
elements, i.e., age, grade of fracture displacement, functional demands, cognitive functions, 
degree of physical fitness and surgeon preference and experience. The surgical procedure 
differs worldwide but mainly includes internal fixation and hip arthroplasty. Options for 
internal fixation include multiple screws or pins (2 or 3), and compression screw and a slide 
plate (Figure 2). Options for hip arthroplasty include HA and THA (Figure 3). 
 
      Figure 2: Option for internal fixation (IF) 
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Figure 3: Options for arthroplasty 
                                       
                  Cemented HA                           THA with a cemented stem                 THA with an uncemented stem 
 
Internal fixation (IF)  
Internal fixation (IF) was the dominant surgical procedure for all types of FNFs in 
Scandinavia until the beginning of the past decade. In Sweden, 87% of patients with 
displaced FNF were treated with IF in 1998, although this value decreased to 14% in 2015. IF 
is still the treatment of choice for undisplaced FNFs (Garden 1 - 2) despite a failure rate of up 
to 20% [34-39]. Most surgeons advocate IF as the treatment of choice for displaced FNF 
(Garden grade 3 - 4) in patients younger than 65-70 years of age to preserve the natural 
femoral head in young patients with high functional demands [40]. The failure rate in this 
patient group is lower than that in elderly patients [41]. Another cause of the preference for IF 
in this patient group is a longer life expectancy and a higher risk for revision surgery after 
arthroplasty. In the frailest elderly patients, IF is often the only possible solution. Avascular 
necrosis, non-union (pseudoarthrosis) and mechanical failure are the most frequent hip-
related complications after a displaced FNF treated with IF. Of the patients treated with IF 
after a displaced FNF, 30-50% who suffer from these complications often require a 
reoperation with arthroplasty [42-44]; therefore, the method has been strongly questioned.  
  7 
Hip arthroplasty 
A number of clinical studies with short-, intermediate- and long-term follow-up periods have 
demonstrated that arthroplasty is the treatment of choice for relatively healthy, active and 
lucid elderly patients with a displaced FNF compared with IF [42-56]. A significantly lower 
rate of reoperation for arthroplasty than for IF has been recognized in many randomized 
controlled trials (RCTs) with follow-up periods longer than 10 years [44, 55, 56]. The pain 
and functional outcomes of patients who underwent surgery using IF without healing 
complications was never better than in that of patients who had a successful primary 
arthroplasty procedure [44]. Arthroplasty as salvage for failed IF has been shown to result in 
a worse outcome than primary arthroplasty [57]. The optimal surgical procedure in elderly 
patients with displaced FNF and cognitive dysfunction remain controversial [58-62]. 
Previous direct comparisons have not identified obvious advantages of performing 
arthroplasty over IF in this patient group because of the poor results regardless of the surgical 
procedure [48, 58, 59]. However, studies using modern cemented HA showed good results in 
this patient population [60, 61]. Two types of arthroplasty have been used for displaced FNF: 
HA and THA. The implants in hip arthroplasty are fixed to the bone with or without bone 
cement (polymethyl methacrylate).  
Hemiarthroplasty 
HA is the most commonly used treatment for displaced FNF and the preferred method in 
elderly patients with low functional demands [40, 44]. Treatment with HA consists of 
replacing the femoral head and leaving the acetabulum intact to articulate with a large metal 
head. There are three different types of HA prostheses: monoblock, modular unipolar and 
modular bipolar (Figure 4). 
The monoblock HA prosthesis is manufactured in one segment; thus, the surgeon is unable to 
change the length of the neck or the offset. The higher complication rates and poor results 
have led to change to modular components. Currently, monoblock implants are regarded as 
outdated [63]. 
 Modular unipolar HA prostheses are manufactured in two segments: the stem and the head. 
The metal head is solid and constructed to the same size as the measured original femoral 
head. The modular bipolar HA prosthesis has been developed to decrease the acetabular 
erosion caused by the friction between a large solid metal head and the acetabulum cartilage 
of the patient. The prosthesis has an inner spherical metal head that fits into a polyethylene 
shell, which in turn is enclosed by a metal cap that articulates with the acetabulum. This 
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design allows for movement not only between the acetabulum and the head but also between 
the inner head and the shell. The movement between the metal head and the shell 
theoretically reduces erosion. Many clinical trials have not observed improved surgical 
outcomes with the use of bipolar implants compared with those for unipolar implants [64-67], 
although less acetabular erosion has been observed [65, 67]. However, recent studies 
comparing the types of HA have shown a higher rate of dislocation and risk for reoperation in 
patients treated with bipolar HA than in those treated with unipolar HA [68, 69]. The use of 
bipolar HA has been reduced in Sweden as a result of these studies. 
Figure 4: Types of hemiarthroplasty 
                                                                                                                                               
     Monoblock HA                     Modular unipolar HA                           Modular bipolar HA   
 
Total hip arthroplasty   
In THA, both the femoral head and acetabulum are replaced. THA is the preferred procedure 
for relatively healthy active and lucid elderly patients with displaced FNF rather than IF [42-
56]. However, the type of arthroplasty, HA or THA, is still debated. Is there any advantage to 
replacing the healthy acetabulum with a prosthetic cup in the healthy, cognitive intact elderly 
patient? Most surgeons seem to prefer HA for elderly patients with low functional demands 
in the absence of arthritic changes in the hip. Many RCTs comparing HA with THA have not 
observed a functional difference and thus have not recommended THA as a standard 
treatment for displaced FNF in elderly patients [70, 71]. However, many RCTs have 
recommended THA over HA in healthy, cognitively lucid and relatively active patients [45, 
72-76]. A large cohort study found that patients who were treated with THA had a lower 
level of pain and a higher level of satisfaction than patients who were treated with HA or IF 
[77]. The majority of the studies are conducted in a subgroup of patients who are active and 
living in their own homes and do not present cognitive alterations. The study settings are, 
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with few exceptions [71, 72, 75], composed of a relatively large population of patients less 
than 80 years of age. Surgeons favouring HA rely on the lower rate of dislocation, shorter 
operation times, less blood loss and less technically demanding surgery, whereas surgeons 
favouring THA rely on the tendency for improved hip function and quality of life. The 
longevity and level of activity of today’s elderly increase the risk for protrusion of the 
femoral head in the acetabulum and, consequently, the need for revision surgery [73].  
CONSIDERATIONS RELATED TO THE TREATMENT 
Cemented or uncemented fixation 
The fixation of a prosthesis to the bone can be performed with or without bone cement 
(polymethyl methacrylate (PMMA) [78]). PMMA was used first as a cement in dentistry, and 
Sir John Charnley popularized its use in orthopaedics whilst developing his low friction joint 
arthroplasty [79]. Mckee and Watson developed prostheses in the late 1940s and 
experimented with the dental acrylic cement PMMA for fixation. In cemented arthroplasty, 
the prosthesis is fixed to the bone by creating an interface between the bone and the 
prosthesis. The uncemented prosthesis was used earlier in time than the cemented prosthesis. 
Dr. Moore inserted the first uncemented prosthesis at John Hopkins Hospital in 1940 in a 
patient with a recurrent giant cell tumour [80]. Böhlman and Moore refined their implant, and 
in 1952, they described a model that featured a fenestrated stem, which allowed bone 
ingrowth. These implants were the first widely used hip arthroplasty products. In uncemented 
arthroplasty, the prosthesis is inserted by high contact with the bone and fixed via a press-fit 
procedure or using a taper-form prosthesis. The question of whether the prosthesis should be 
cemented in patients with FNF is widely debated but until now has not been resolved. 
Comparisons between cemented and uncemented stems in hip arthroplasty for patients with a 
FNF have almost consistently favoured cemented fixation, which is mainly because of the 
superior outcomes regarding pain relief, walking ability, use of walking aids, and activities of 
daily living [81] as well as the a higher incidence of complications with uncemented stems, 
such as peri-prosthetic fracture [82]. However, recent reports on modern uncemented, 
hydroxyapatite-coated femoral stems used for this patient group have shown promising 
early results [83-85]. In addition, bone cement implantation syndrome (BCIS) is more 
prevalent in cemented stems than in uncemented stems and in patients with a FNFs [86]. 
BCIS is a well-described complication of cemented hip arthroplasty, and it is characterized 
by a number of systemic clinical features: drop in systolic blood pressure, hypoxemia, 
pulmonary hypertension, cardiac dysrhythmias, and occasionally cardiac arrest and death 
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[87, 88]. BCIS is classified into three grades according to Donaldson [89]. Grade 1: 
moderate hypoxia (SpO2<94%) or hypotension (fall in systolic blood pressure) (SBP>20%). 
Grade 2: severe hypoxia (SpO2<88%), hypotension (fall in SBP >40%) or unexpected loss 
of consciousness. Grade 3: cardiovascular collapse requiring cardiopulmonary 
resuscitation. Severe BCIS has a substantial impact on early and late mortality [90]. The 
true incidence of BCIS in cemented arthroplasty for hip fractures is not known, which is 
mainly because an agreed upon standard definition has not been available until recently. In 
a study of 1016 patients who underwent cemented HA, Olsen et al. [90] found that 21% were 
grade 1, 5.1% were grade 2 and 1.7% were grade 3, and the early mortality was 9.3% in 
BCIS grade 1, 35% in grade 2 and 88% in grade 3. Thus, the use of uncemented 
hydroxyapatite stems for this patient group may still be justified.  
Cognitive dysfunction and femoral neck fractures 
Cognitive dysfunction is associated with an increased risk of sustaining a hip fracture, and the 
prevalence of impairment in cognitive function among hip fracture patients has been reported 
to reach 55% [91, 92]. Patients with cognitive dysfunction are plagued with a high mortality 
rate and a high rate of general and fracture-related complications [17, 48, 93, 94]. This 
subgroup of patients is often excluded in clinical trials, which has resulted in a failure to 
improve their outcomes and identify their risk factors of a poor prognosis [95]. The functional 
outcomes of patients with FNF and cognitive dysfunction treated with HA has been sparsely 
investigated, and evidence is lacking for the effect of post-operative rehabilitation in this 
subpopulation. Previous studies comparing HA and IF in this population have provided 
contradictory results [58-61].  
Surgical approach in hip arthroplasty 
Many surgical approaches to the hip joint have been mentioned in the literature. The four 
most commonly used in the clinical practice include anterior, anterolateral, direct lateral 
and posterior lateral approaches. The most frequently used approaches in hip arthroplasty 
are the direct and posterior lateral approaches [96-98]. In Sweden, 71% of hip fractures 
were operated using the direct lateral approach in 2016. The direct lateral approach is 
linked to increases in the prevalence of superior gluteal nerve damage, gluteus medius 
insufficiency and trochanter tenderness [99-102]. However, many authors have not observed 
clinically relevant effects [103, 104]. The posterior lateral approach is linked to an increased 
risk of reoperation because of prosthetic dislocation in patients who are treated for both 
osteoarthritis and FNF [105, 106]. The direct lateral approach has been proven to reduce the 
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dislocation rate after hip arthroplasty compared with the posterior lateral approach [68, 69, 
107-109]. 
OVERALL AIM OF THE THESIS  
The overall aim of this thesis was to define the optimal treatment for elderly patients with 
displaced fractures of the femoral neck with consideration of the patients’ age, functional 
demands and cognitive function. 
AIMS OF THE STUDIES 
STUDY I 
To compare the results of total hip replacement with those of IF in patients over 65 years of 
age with displaced FNF over a long-term follow-up period of seventeen years. 
STUDY II 
To compare the effectiveness and safety between a modern cemented and a modern 
uncemented hydroxyapatite-coated femoral stem in patients 65–79 years of age who were 
treated with THA for displaced FNF. 
STUDY III 
To compare the results of HA with those of THA in patients older than 80 years of age with a 
displaced FNF.  
STUDY IV 
To investigate the outcome after cemented HA for displaced FNF in elderly patients with 
cognitive dysfunction and to examine the impact of post-operative rehabilitation. 
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HYPOTHESES OF THE STUDIES 
I. THA in healthy elderly patients would yield significantly better functional results and 
fewer reoperations than IF over the long term. 
II. An uncemented femoral stem used in THA for a displaced FNF would not be associated 
with more adverse peri-operative and post-operative events than a THA using a cemented 
stem, and the health-related quality of life (HRQoL) of the patients would be equivalent at 2 
years. 
III. THA could result in superior hip function, HRQoL and an absence of increasing rates of 
complications and reoperations compared with HA in cognitively intact elderly patients aged 
greater than 80 years treated for displaced FNF. 
 IV. Cemented HA with a direct lateral approach is an acceptable option and will not lead to 
more hip-related complications and reoperations in elderly patients with cognitive 
dysfunction or dementia than in patients who did not present cognitive dysfunction and were 
treated for a FNF. 
END POINTS 
STUDY I 
The primary endpoint was hip function evaluated with the Harris hip score. Secondary end 
points included mortality, hip-related complications, reoperation, gait speed, pain in the 
involved hip and activities of daily living (ADL). 
STUDY II 
The primary endpoints were the prevalence of all hip-related complications and HRQoL 
evaluated with the EuroQol-5D (EQ-5D) index up to 2 years after surgery. Secondary 
endpoints included overall mortality, hip function and general medical complications 
STUDY III 
The primary endpoints were hip function and HRQoL evaluated with the Harris hip score and 
the EQ-5D index, respectively. Secondary endpoints included hip-related complications and 
reoperations, mortality, pain in the involved hip, ADL, surgery time, blood loss and general 
complications.  
STUDY IV 
The main endpoints were the prevalence of all hip-related complications and the ability to 
return to previous walking status. Other outcomes included mortality, HRQoL (according to 
the EQ-5D index), hip function, ADL, pain numeric rating scale (PNRS) and adverse events 
during the study period. 
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PATIENTS 
All patients with a FNF who were admitted to the Orthopaedic Department at Danderyd 
Hospital between February 1990 and December 1994 (study I), between 2009 and 2014 
(study II) and between 2009 and 2016 (studies III and IV) were screened for participation in 
the study during the inclusion period. We identified 1172 patients for study I and 1224 
patients for studies II, III, and IV who were admitted because of a FNF.  
The inclusion criteria were as follows.  
• An acute displaced FNF (Garden III–IV) that had been sustained within the 
previous 36-48 hours.  
• Ability to ambulate independently with or without walking aids.  
• Age of 65 years or more in study I. 
• Age of 65–79 years in study II.  
• Age of 80 years or more in study III. 
• Age of 65 years in the cognitive dysfunction group and 80 years and over in the 
control group in study IV. 
• Admission from home, a healthy status or only mild systemic disease (ASA 1 or 2), 
ability to conduct all ADL (Katz index A) and a Harris hip score (HHS) of 100 points 
prior to the fracture in study I. 
• Intact cognitive function, no diagnosis of dementia, lucidity and fully oriented in 
study I and at least 8 correct answers on a 10-item SPMSQ in studies II, III and in 
the control group in study IV. For patients with cognitive dysfunction in study IV, 
the condition was defined as a known diagnosis of dementia and/or a SPMSQ of ≤7. 
 
Exclusion criteria included patients with osteoarthritis or rheumatoid arthritis in the 
fractured hip, pathologic fractures, inability to walk, concurrent joint disease or previous 
fracture in the lower extremities. We also excluded patients who were deemed unsuitable for 
an arthroplasty by the anaesthesiologist because of severe comorbidities and those who 
were unsuitable for participation in the study for any other reason. 
 
In study IV, the differences in age in relation to mental status were related to the clinical 
routines at the Orthopaedic Department of Danderyd Hospital; a cemented HA is used for 
patients greater than 65 years with cognitive dysfunction and in those greater than 80 years 
without cognitive dysfunction. THA is used in relatively young (65-79 years) lucid patients. 
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The patients who fulfilled the inclusion criteria and agreed to participate in the study gave 
their oral and written informed consent to participate in the study. Consent for patients with 
cognitive dysfunction was obtained from relatives or significant others.  
 
Ethics 
All studies were conducted in accordance with the Helsinki Declaration, and all protocols 
were approved by the local ethics committee. The patients in studies I, II, and III gave their 
informed consent to participate. In study IV, the patients or their caregivers gave oral and 
written informed consent to participate in the study. 
REGISTRATION  
Studies I, II, III were registered and are publicly accessible at www.clinicaltrials.gov. 
Study I: NCT01344772 
Study II: NCT02247791 
Study III: NCT022463 
MATERIAL 
INTERNAL FIXATION 
The osteosynthesis device used in study I was two Olmed screws (Olmed; DePuy/Johnson & 
Johnson, Sollentuna, Sweden). 
HIP ARTHROPLASTY  
In study I, all patients undergoing THA received a cemented, polished, tapered femoral 
stem manufactured from a titanium alloy (Ti-6Al-4V) (Bi-Metric; Biomet UK, Brigend, 
South Wales, United Kingdom) with a 28-mm chromium cobalt head. The acetabular 
component was a cemented polyethylene acetabular component (Müller; Biomet UK). The 
bone cement used was Optipac (Biomet, Malmö, Sweden). 
An uncemented Bi-Metric stem (Biomet, Warsaw, Indiana, USA) was used in the 
uncemented group in study II. The Bi-Metric stem is a tapered, collarless, proximally 
coated (plasma-sprayed, commercially pure [CP]) titanium femoral stem. The modular 
collarless, polished, tapered femoral stem CPT (Zimmer, Warsaw, Indiana, USA) was used 
in study II and used up to 2014 in studies III and IV. After 2014, the hospital switched to a 
  15 
cemented, matte, anatomical, collared femoral stem Lubinus SP II (Waldemar Link, 
Hamburg, Germany) according to a decision in our clinic. We used the 32-mm cobalt-
chromium head in all patients in studies II, III and IV. For the acetabular component, we 
used a cemented highly crosslinked polyethylene acetabular component Marathon cup 
(DePuy, Warsaw, Indiana, USA) in all patients except three who obtained the uncemented 
Trilogy cup (Zimmer, Warsaw, Indiana, USA) according to the surgeon’s preference.  
 A modular 32-mm cobalt chrome femoral head and a modular unipolar head Versys Endo 
(Zimmer, Warsaw, Indiana, USA) or unipolar head (Waldemar Link®, Hamburg, 
Germany) were used for THA patients and HA patients, respectively, in studies II, III and 
IV. 
 Bone cement (Palacos with gentamicin; Schering-Plough, Stockholm, Sweden) was used in 
all patients who received a cemented stem in studies II, III and IV.  
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METHODS 
STUDY PROTOCOL 
Study I  
A prospective RCT conducted between February 1990 and June 2010 (inclusion period 
February 1990 to December 1994). The randomization process for the first 20 patients was 
conducted using sealed opaque envelopes. No stratification was used. Because of hospital 
economic and logistic reasons related to a lack of operating theatre staff with THA 
experience during weekends, a change in allocation routines was implemented during the 
study. Thus, the following 80 patients were allocated according to the weekday they were 
admitted. Patients admitted on Monday to Thursday underwent THA, whereas patients 
admitted from Friday to Sunday underwent IF. The patients, surgeons and staff were not 
blinded to the choice of treatment. Follow-up examinations at 3 months and 1, 2, 4, 11 and 17 
years were performed in the Orthopaedic Department at Danderyds Hospital, Sweden. 
Studies II and III 
Single-centre, single-blinded RCTs were performed between 2009 and 2016 (study II 
(CHANCE trial); inclusion period, September 2009 through March 2014) and between 
2009 and 2017 (study III (Hope-Trial); inclusion period, September 2009 to April 2016). The 
patients were block-randomized in groups of 10 at a 1:1 ratio to receive either a cemented 
or an uncemented stem in study II and either a HA or THA in study III. We used sealed 
envelopes, and randomization was stratified by sex to ensure that the sex distribution would 
be the same in both groups. The participants, who were the primary outcome assessors, 
were blinded to the choice of treatment, and they were not allowed to view their X-rays. To 
verify that the blinding was maintained during the study, the patients were asked whether 
they knew their assigned treatment at the 1-year follow up. The surgeons and staff were not 
blinded during the study. Follow-up examinations were performed at 3 months and 1 and 2 
years for study II and at 3 months and 1 year for study III in the Orthopaedic Department at 
Danderyds Hospital. 
Study IV 
A single-centre, prospective, observational cohort study was conducted between September 
2009 and March 2017 (inclusion period, September 2009 to March 2016). Patients with a 
displaced FNF treated with a HA using a direct lateral approach were included in the study. 
The cohort was divided into two groups: a cognitive dysfunction group, which was defined 
by a diagnosis of dementia and/or a SPMSQ of ≤7; and a control group, which was defined as 
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by absence of a diagnosis of dementia and with a SPMSQ ≥8, and these patients were 
recruited from the HA group of study III (HOPE-trial). We used a directed acyclic graph 
approach (Figure 5) to identify possible confounders [110]. Follow-up examinations at 3 
months and 1 year were performed in the Orthopaedic Department at Danderyds Hospital. 
Figure 6 shows the flow diagram of the patients in this thesis. 
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Figure 5: Directed acyclic graph (DAG) for the statistical model. The variables shown in 
solid colours have been adjusted, and those that are shaded have not. The DAG is a tool that 
illustrates our interpretation of how the data are interconnected. Per definition, it is a 
simplification and a tool for the reader to better understand the underlying assumptions of the 
study. 
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Figure 6: Flow diagram of patients in the thesis 
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FRACTURE CLASSIFICATION 
All patients in the four studies had a displaced FNF classified as Garden III-IV except for 
certain patients for whom the fracture was classified as Garden I or II but was assessed as 
subcapital and not appropriate for IF because of the high risk of failure. 
ASA CLASSIFICATION AND ANAESTHESIOLOGICAL ASSESSMENT 
The patient’s general physical health status in all studies was assessed by an 
anaesthesiologist according to the ASA classification [111]. ASA 1 indicates a completely 
healthy person; ASA 2 indicates a person with mild systemic disease; ASA 3 indicates a 
person with severe systemic disease that is incapacitating; ASA 4 indicates a person with an 
incapacitating disease that is a constant threat to life; and ASA 5 indicates a moribund 
patient who is not expected to live 24 hours with or without surgery. In study I, only 
patients with ASA 1-2 were included. In the others studies in this thesis, patients with ASA 
1, 2, 3 and 4 were included. All patients in the four studies were examined and cleared by an 
anaesthesiologist before inclusion. The assessment included a decision regarding whether the 
patient was healthy enough for both procedures in all studies. 
COGNITIVE FUNCTION 
Cognitive function was assed using the SPMSQ [112]. The SPMSQ is a validated test with 
10 questions, where 8–10 correct answers are classified as intact cognitive function, 3–7 
correct answers are classified as an intermediate level (mild-moderate) of cognitive 
dysfunction and 0–2 correct answers are classified as a severe level of cognitive dysfunction 
(see appendix). The SPMSQ has shown good sensitivity and specificity for detecting 
cognitive dysfunction and has been validated for screening cognitive dysfunction in the 
elderly population [113, 114]. Cognitive function is a strong predictor of outcome after hip 
fracture surgery [17, 115]. The SPMSQ was used in studies II, III and IV. In studies II and 
III, only patients with at least 8 correct answers were included. In study IV, patients with 
fewer than 8 correct answers or with a diagnosis of dementia were included. In study I, we 
did not use any validated instrument for assessing cognitive function. However, the 
inclusion criteria included intact cognitive function (no diagnosis of dementia, with the 
patient being lucid and fully oriented).  
CHARNLEY CLASSIFICATION   
The Charnley classification was used preoperatively in studies II, III and IV. This 
classification has a simple design with 3 classes: (A) 1 hip involved, (B) 2 hips involved 
but no other joints, and (C) some other factor contributing to a failure to achieve normal 
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locomotion, such as rheumatoid arthritis, senility, hemiplegia, or cardiovascular or 
respiratory disability [116] (please see the appendix). 
LIVING CONDITIONS  
In study I, living conditions were categorized as independent for patients admitted from 
their own home, and only these patients were included in the study. In the other studies 
included in this thesis, living conditions were categorized as independent (i.e., living in own 
home, retirement community or block of service flats) or as institutionalized (i.e., care 
homes for demented patients or nursing homes). Patients were included in studies II, III, 
and IV regardless of their living conditions. 
HARRIS HIP SCORE (HHS) 
Hip function was assessed in all studies in this thesis using the HHS [117]. The score was 
originally developed for hip function evaluations of arthroplasty after traumatic arthritis. This 
score has been widely used for evaluating hip function after THA and has been proven to be a 
valid and reliable score in patients after THA [118]. The HHS was originally surgeon-
assessed but has been validated for self-reporting and outcomes after FNF [119, 120]. The 
total sum of all the points generates a maximum score of 100: pain (0–44 points); function 
(0–47 points); absence of deformity (0–4 points); and range of motion (0–5). A higher score 
corresponds to better hip function. Except for the range of motion dimension, the HHS is 
self-reported by the patient. In this thesis, the assessment of the HHS was performed via 
interviews, with the grading of pain and function accounting for a total of 91 points (see the 
appendix). The HHS was modified in this thesis for use as a patient self-reported 
questionnaire by excluding the clinical examination domain. This modification has 
previously been evaluated and found to be in accordance with the surgeon-assessed HHS 
[119]. The modified HHS is used in all studies in this thesis.   
GAIT VELOCITY AND WALKING ABILITY 
Gait speed was measured as the time in seconds to walk 30 m with a comfortable velocity, 
and it was used in study I. The ability to return to previous walking ability and changes in the 
walking distance were assessed using question number 4 of the HHS. Walking ability was 
graded from 0 to 11 points, where 0 points equals non-walking ability, 2 points equals a 
walking distance less than 0.5 km or walking only indoors, 5 points equals a walking distance 
from 0.5-1 km, 8 points equals a walking distance from 1-2 km and 11 points equals a 
walking distance greater than 2 km. 
 22 
EQ-5D 
The quality of life was assessed with the EuroQol [121]. The EuroQol consist of 4 
components: the health status part (EQ-5D), a visual analogue scale (EQ-VAS), the valuation 
part and the background data. The health status part (EQ-5D) was used in this thesis in 
studies II, III and IV. EQ-5D is widely used and has been translated into most major 
languages, including Swedish [121, 122]. The EQ-5D is a standardized non-disease specific 
instrument that measures quality of life using five dimensions: mobility, self-care, usual 
activity, pain/discomfort and anxiety/depression. Each dimension is divided into 3 levels: 1, 
no problems; 2, certain problems; and 3, extreme problems (see appendix). A unique health 
state is defined by combining 1 level from each of the dimensions, which results in 243 
different health states. We used the preference scores (EQ-5D index scores) generated from a 
large population study in the United Kingdom [123]  when calculating the scores for our 
patients. The states can be expressed as index scores ranging from -0.59 points (indicating the 
worst possible quality of life) to 1.0 (indicating the best possible quality of life), with 0 on the 
scale representing the state of being dead. Negative scores suggest that he corresponding 
health states are considered worse than being dead. The EQ-5D has been used in clinical 
trials in many different fields of medicine, including quality of life evaluations after hip 
fracture surgery [72, 124]. The responsiveness has been found to be adequate in patients 
with FNF [125, 126]. Preinjury EQ-5D was obtained using the recall principle, in which the 
patients were asked to recall their health status one week prior to injury. This method has 
been proven to be a valid measure [127]. In patients with cognitive dysfunction, the EQ-5D 
was obtained from the proxy, i.e., relatives or significant others. This method is also well 
documented [128, 129] 
ADL 
The status of the ADL index according to Katz et al. [130] was used in all studies in this 
thesis and is based on an evaluation of the functional independence or dependence of patients 
during bathing, dressing, going to the toilet, transferring, continence and feeding. ADL index 
A indicates independence in all six functions, index B indicates independence in all but one 
function, and indices C to G indicate dependence in bathing and in one to five other 
functions (see the appendix). 
PAIN NUMERIC RATING SCALE 
Pain in the involved hip was measured with the PNRS [131]. The PNRS is a 10-point (1-10) 
numerical rating scale that is easy to administer. A score of 0 indicates no pain, and score of 
10 indicates the worst possible pain (See appendix). The PNRS was used in the four studies 
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in this thesis. Patients were asked to evaluate the level of pain they experienced in the 
operated hip during the previous week. 
SURGICAL TECHNIQUE 
Internal fixation (IF) 
 IF was used in study I, and it was conducted with the patient on a fracture table. The 
fracture was reduced closed, with the aid of an image intensifier, and it was fixed with two 
cannulated screws (Olmed; DePuy/Johnson & Johnson, Sollentuna, Sweden). Capsulotomy 
or joint aspiration was not performed. In the anteroposterior projection, the distal screw was 
aimed to the level of the lesser trochanter to rest on the medial inferior cortex of the femoral 
neck. The proximal screw was positioned parallel to and at least 1 cm from the distal screw. 
The screws were parallel and positioned in the central or posterior third of the femoral head 
and neck. All operations were performed on the day of admission or the following day.  
Hip arthroplasty 
The posterior lateral approach without repair of the capsule or external rotational was used 
in study I [132]. The direct lateral approach was used in studies II, III, and IV [133]. The 
following surgical techniques and instrumentation were identical, regardless of the type of 
arthroplasty or approach. The femoral head was dislocated from the acetabulum, and 
resection of the femoral neck was performed. When performing a HA, the femoral head is 
measured and the head size is determined. When performing a THA, the acetabulum is 
prepared with reaming until the cartilage and cortical bone are removed. The acetabular 
component was positioned and fixated with bone cement. In the uncemented group in study 
II, the femur was reamed until cortical bone contact was obtained. The proximal femur was 
then prepared with broaches of increasing size until rotational stability was achieved. In the 
cemented stem, the proximal femur was reamed with 1 or 2 reams and then prepared with 
broaches of increasing size. The cement bed was cleaned with repeated high-pressure 
pulsatile lavage. A distal restrictor was used when cementing the femoral component.  
As thromboprophylaxis, dextran (Macrodex; Meda, Sweden) was used one hour 
preoperatively and postoperatively daily for four days in study I, whereas low-molecular-
weight heparin was used in studies II, III and IV postoperatively for at least 10 days. 
Antibiotic prophylaxis with cloxacillin (Ekvacillin; Meda, Sweden) (2 g) was administered 
preoperatively followed by 3 additional doses during the first 24 h.  
Under the supervision of a physiotherapist, all patients were mobilized to full weight-bearing 
capacity on the first post-operative day. In the THA group in study I, the patients were 
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allowed to sit on a high chair and could stop using crutches at their own discretion. After six 
weeks, no restrictions were imposed. In studies II, III and IV, the patients were mobilized 
without any restrictions on the first post-operative day. 
RADIOLOGICAL ASSESSMENT 
In study I, an anteroposterior (AP) view of the pelvis and AP and lateral views of the hip 
were obtained pre- and postoperatively and at the follow-up visit. The plain radiograph was 
used. The positioning of the prosthetic components was evaluated and classified as follows. 
• Good 
o minimum circumferential cement mantle around cup and stem, 2 mm; 
o abduction angle of the cup, 35°-55°; 
o anteversion angle of the cup, 10°-25°; 
o  varus/valgus angle of the stem, below 3°;  
o post-operative limb-length difference, below 10 mm.  
• Fair 
o at least four of the five categories graded as good.  
•  Poor   
o three categories or fewer graded as good.  
In patients treated with IF, the reduction and position of the screws was categorized in 
accordance with the recommendations of Tidermark et al. [51] as follows  
• Good (displacement <2 mm; Garden angel 160° to 175°; and posterior angulation 
<10o); 
• Fair (displacement <5 mm; Garden angel 160° to 175°; and posterior angulation 
<20°); 
• Poor (displacement >5 mm; Garden angel <160° or > 175°; and posterior angulation 
>20°). 
In the THA group, we examined the radiographs for radiolucent lines around the stem in 
the zones of Gruen et al. [134] and around the cup in the zones of DeLee and Charnley 
[135] Any circumferential radiolucent lines around the implants were defined as loosening. 
In the IF group, healing of the fracture was defined as the presence of visible trabeculations 
across the fracture line and no signs of osteonecrosis. The absence of radiographically 
visible trabeculations across the fracture line and progressive or early displacement was 
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defined as a non-union. 
In study II, an AP view of the pelvis and AP and lateral views of the hip were obtained pre- 
and postoperatively and also at 24 months, and these were reviewed by an independent 
radiologist. All femurs were classified preoperatively as type A, B, or C according to the 
Dorr classification [136]. Post-operative heterotopic ossification at 24 months was graded 
as described by Brooker et al. [137]. 
 In studies III and IV, an AP view of the pelvis and AP and lateral views of the hip were 
obtained pre- and postoperatively. Radiological measurements at one year were not 
performed because one year is a relatively short time for any routine radiological change to 
occur. A digital radiograph was used in studies II, III and IV. 
STATISTICAL METHODS 
In all studies, the statistical software SPSS Statistics 18.0-22.0 for Mac was used. Sample 
size calculations were performed using the software Sample Power 2.0. In all studies, P-
values ≤0.05 were considered significant.  
Sample size calculation  
In study I, no formal power analysis was performed at the time of initiation of the study. An 
interim analysis (two-sided, p=0.05) after one year was performed on the primary end 
point, and we tested the null hypothesis that the mean HHS for the two groups would be 
equal. We assumed that a mean difference of 10 points (standard deviation 15 points) in the 
HHS was the smallest effect that would be clinically relevant. Taking into consideration the 
difference in the number of patients included in the two groups, we calculated that a total of 
90 patients with a one-year follow-up period (40 in the THA group and 50 in the IF group) 
would provide a power of 87.5% to yield a significant result. A total of 100 patients (43 in 
the THA group and 57 in the IF group) were recruited to allow for any loss to follow up. 
In study II, 60 patients in each group with a non-inferiority limit of 15% would be required 
to show non-inferiority at a power of 80% of the primary endpoint, all hip-related 
complications between the two groups with a total assumed complication rate of 20%. In 
addition, 40 patients in each group with a non-inferiority limit of 0.1 would be required to 
show non-inferiority at a power of 80% of the primary variable (HRQoL), which was 
measured via the EQ-5D and presented an assumed value of 0.73 (SD 0.18). Both 
calculations were performed with significance set to p<0.025 instead of p<0.05 to handle 
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multiplicity. Because this patient group has a 1-year mortality of 10%, 70 patients in each 
group (140 total) would be sufficient for the study. 
In study III, prior to commencement of the study, a two-sided power analysis was performed. 
We wanted to test the null hypothesis assuming that the mean HHSs for the two groups will 
be equal. We assumed that a mean difference of 10 points (standard deviation, 15 
points) [138] in the HHS is the smallest effect that will be clinically relevant. We calculated 
that a total of 80 patients (40 in each group) would have a power of 80% to yield a significant 
result. 
This calculation also assumes that a sample of 40 patients in each group would be required 
to show to non-inferiority (non-difference) at a power of 80% of the second endpoint EQ-
5D, which had an assumed value of 0.73 and a standard deviation of 0.18. The significance 
level was set at a conservative 2.5% (p<0.025) to handle multiplicity because two sample 
size calculations were included. We will include 60 patients in each group (120 total) to 
allow for loss to follow up. 
In study IV, 50 patients in each group are required to show non-inferiority at a power of 80% 
of the primary variable complication rate between the two groups (patients included in study 
III versus patients with HA in study IV), with a total assumed complication rate of 30%. In 
addition, 40 patients in each group are required to show non-inferiority at a power of 80% of 
the secondary variable HRQoL as measured using the EQ-5D, with an assumed value of 0.73 
(SD 0.18) one year after the surgery. Both calculations were conducted at p<0.025. Because 
this patient group with severe cognitive impairment has a high mortality rate, we will include 
100 patients to allow for loss to follow up. 
Statistical analysis 
In studies I-III, analyses of the outcomes were based on the intention-to-treat principle, and 
all patients remained in the group to which they had been randomized regardless of any 
later surgical intervention. The data in all studies are presented with the mean differences and 
SDs, relative risk, odds ratios (ORs) and uncertainty estimation with 95% confidence 
intervals (CIs). A P-value <0.05 was considered statistically significant 
In study I, patients with missing data at any of the follow-up evaluations were analysed 
with the last observation carried forward. For the clinical outcome variables (HHS, gait 
velocity, and VAS), we used a one-way repeated measure analysis of covariance 
(ANCOVA) to detect an overall difference between the two treatment arms throughout the 
study period using the estimated marginal means to adjust for the difference between the 
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two groups in terms of sample size. The Bonferroni correction was used to adjust for 
multiple comparisons. Kaplan-Meier curves with the log-rank test were used to analyse 
patient and implant survival. 
In all studies, Student’s t-test and Levene’s test were performed to compare scaled 
variables, and Fisher’s exact test was used to identify correlations between ordinal data. In 
study IV, a linear regression model was used to evaluate the HRQoL and hip function and a 
binary logistic regression was used to evaluate the risk of being unable to walk at the 1-year 
follow up. The factors used in the models were group (controls/cognitive dysfunction), 
geriatric rehabilitation after surgery (yes/no), pre-fracture function (EQ-5D/HHS and walking 
ability, respectively), age and sex. Two types of sensitivity analyses were performed to test 
the robustness of our models. First, because of the relatively large amounts of missing 
functional outcome score data at the 1-year follow up because of the high mortality rate, 
multiple imputation was used. Second, a competing risk analysis for hip complication 
outcome (according to Fine and Gray) with the exposure variable, age, sex, and ASA-class as 
the co-variates were used because of the higher mortality rate in the cognitive dysfunction 
group. We used SPSS 22 for Mac for the analyses. 
  
 28 
RESULTS 
STUDY I 
Patient flow and baseline data 
In total, 1172 patients with FNF were admitted to the Orthopaedic Department at Danderyd 
Hospital, Stockholm, Sweden (flow of patients, Figure 7) during the study period. Of these, 
100 patients met the inclusion criteria [mean age 78 years (range, 65-90 years, with 79 
females)] and were recruited to participate in the study. All subjects received their allocated 
treatment. The characteristics of the two groups were similar at baseline (Table 1).  
Operative data  
A total of 18 surgeons performed all the operations, and a greater proportion of IF was 
performed by the registrars (THA versus IF and consultants/registrars: 41/2 versus 47/10). 
The duration of surgery and blood loss were greater in the THA group. The THA was 
graded as good in 40 (93%) patients and fair in 3 (7%). In the IF group, closed reduction 
was categorized as good in 51 (89%) and fair in 6 (11%) patients. The positioning of the 
screws was considered good in 56 (98%) and fair in 1 (2%) patient. We found no 
correlation between the incidence of failed fracture healing and the reduction and 
positioning of the screws. 
Primary endpoint  
The HHS was higher in the THA group, with a mean difference throughout the study period 
of 14.7 points (95% CI 9.2 to 20.1; p<0.001; ANCOVA), and the greatest difference 
between the groups was observed during the first 2 years (Figure 8). 
Mortality   
Patient mortality was high regardless of the treatment. At 11 and 17 years, 34% and 14% 
patients were still living, respectively. The mortality rate did not differ between the groups 
over the study period. 
Hip complications and reoperations 
Forty hips (40%) required at least one reoperation during the study period (Table 2), and 4 
(9%) patients in the THA group and 22 (39%) in the IF group underwent a major reoperation 
(relative risk [RR] 0.24; 95% CI, 0.09 to 0.64; p=0.001) (Table 3). The overall rate of 
reoperation was 23% (10/43) in the THA and 53% (30/57) in the IF group (RR 0.44; 95% CI 
0.24 to 0.80; p=0.003) (Table 3). The median time to first reoperation was 33 months (range, 
0.5-114) in the THA group and 10 months (range, 0.5-47) in the IF group. Twelve patients 
underwent more than 1 surgical procedure (range 1-4), and 10 of these patients were in the IF 
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group. The most frequent complications in the THA group were dislocations (n=6), late-
presenting peri-prosthetic fractures (n=2) and aseptic loosening (n=2). In the IF group, 
avascular necrosis (n=17) and non-union/mechanical failure (n=14) were the two most 
common hip complications. During the first two years after surgery, a large number of IF 
procedures failed, and 20 of the initially recruited 57 patients received a secondary THA. 
Patients who received primary THA underwent fewer reoperations (4 of 43 patients), which 
were performed at later time points (4 to 12 years after primary surgery) (Tables 2 and 3, 
Figure 9). 
Gait speed, pain and activities of daily living 
Gait speed was significantly faster in the THA group at 3 months (THA vs IF; 37 vs 50 
seconds to walk 30 metres, p=0.005) but did not differ between the groups at later follow 
ups. Patients in the THA group had less pain in the operated hip throughout the study 
period. The mean difference was 1.2 points (95% CI 0.4 to 2.0; p<0.001, ANCOVA) out of 
10 on the VAS. A greater proportion of patients in the THA group was fully independent in 
ADL during the 1st year of the study. At the later follow-up visits, differences were not 
observed between the groups (table 4).  
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Figure 7: Flow of the patients in study I. 
 
 
  
CONSORT	2010	Flow	Diagram	
Assessed for eligibility (n=1172) 
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Lost to follow-up (n=3) Deceased (n=23) 
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Allocated to total hip replacement (n=43) 
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♦	Excluded from analysis (n= 0)	
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Table 1: Study population characteristics. Values indicate the number of patients or the 
mean, with percentages or ranges in parentheses. 
 THR (n=43) IF (57) 
Sex 
Male 
Female  
 
5 (12%) 
38 (88%) 
 
16 (28%) 
41 (72%) 
Age 78 (65-90) 79 (66-90) 
Side  
Left 
Right 
 
20 (53%) 
23 (47%) 
 
26 (46%) 
31(54%) 
 
 
 
 
 
Figure 8: Line graph illustrating the mean Harris hip score during the study period 
according to the treatment. 
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Table 2: All complications are counted; thus, more than one complication may apply for 
each each hip. 
No. (%) is presented 
a One hip dislocated 4 times and 5 hips dislocated once in the total hip replacement group.  
Hip complications THR (n=43) IF (n=57) 
Dislocationa 9 1 
Pseudarthrosis/mechanical failure 0 14 
Avascular necrosis 0 17 
Deep infection 0 2 
Lateral pain 1 12 
Aseptic loosening 2 1 
Peri-prosthetic fracture 2 0 
Total number of hip complications 14 47 
Number of hips with any complicationb 11 (26%) 37 (65%) 
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Table 3: Hip reoperations: All reoperations are counted; therefore, more than one reoperation 
may apply for each hip.  a One hip dislocated 4 times and 5 hips dislocated once in the total 
hip replacement group. 
No. (%) is presented 
 
 
 
 
 
 
 
 
 
 
 
Hip reoperations THR 
(n=43) 
IF 
(n=57) 
Closed reductiona 9 1 
Screw removal 0 14 
Excision arthroplasty (Girdlestone) 0 2 
Hip arthroplasty as a secondary or tertiary procedure 0 20 
Open reduction and internal fixation of peri-prosthetic fracture 2 0 
Revision of total hip replacement because of aseptic loosening 2 1 
Surgical debridement because of deep infection 0 2 
Total number of hip reoperations 13 40 
Number of hips with any major reoperation 4 (9%) 22 
(39%) Number of hips with any reoperation 10 (23%) 30 (53%) 
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Figure 9: Line graph of the cumulative reoperation rate during the study period. 
 
 
 
Table 4: Proportion of patients with fully independent activities of daily living according to 
the treatment. 
 THA (n=43) IF (n=57) P-value 
Baseline 100% (43/43) 100% (57/57)  
3 months 85% (33/39) 64% (33/52) 0.03 
1 year 88% (35/40) 70% (35/50) 0.05 
2 years 87% (33/38) 78% (35/45) 0.3 
4 years 82% (28/34) 73% (33/45) 0.3 
11 years 82% (14/17) 79% (11/14) 0.8 
17 years 80% (4/5) 71% (5/7) 0.7 
%. (No) is presented 
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STUDY II 
Patient flow and baseline data 
Sixty-nine patients were recruited to participate in the study (Figure 10). The mean age was 
73 years, and 47 patients were female. There were twice as many patients with ASA 3–4 in 
the uncemented group (Table 5). All subjects received their allocated treatment except for 1 
patient in the cemented group who received a cemented HA instead of a THA. Regarding 
hip complications and reoperations, all patients were available to follow up, including the 3 
patients who refused to attend to their clinical follow-up visits. 
 When only half of the sample size had been reached (n=69), an interim analysis was 
performed, and the results showed that the incidence of hip complications was statistically 
significantly higher in the uncemented group; therefore, the study was stopped. 
Operative data 
The mean surgery time was 13 minutes shorter in the uncemented group. The decrease in 
blood pressure during stem insertion did not (for any individual patient) reach the level that 
occurs in BCIS grade 1 according to Donaldson et al. [89]. Pulse oximetry decreased below 
94% in 1 patient in each group and reached the level of BCIS grade 1. No deaths or 
cardiovascular collapse occurred during the cementing procedure. The operative data are 
presented in Table 6. 
Primary endpoints 
Up to 2 years after surgery, 8 patients suffered at least 1 hip-related complication: 1 in the 
cemented group and 7 in the uncemented group (RR=7; 95% CI, 1–55; p=0.03, Fisher’s 
exact test) (Table 7). Four patients in the uncemented group underwent a major reoperation, 
compared with 0 in the cemented group. The HRQoL EQ-5D was similar, and statistically 
significant or clinically significant differences were not observed between the groups 
during the study period (Table 8). The only complication that occurred in the cemented 
group was a dislocation of the prosthesis, which was treated with a closed reduction. In the 
uncemented group, 3 intra-operative peri-prosthetic fractures occurred. Two of these 
fractures were treated with cerclage wires, and the third was treated with a plate and screws. 
All fractures healed, but 1 stem had excessive migration, and the patient continued to 
experience pain. The stem was later revised to a cemented stem. One additional peri-
prosthetic fracture (18 months postoperatively) was fixed with cerclage wires, and the stem 
was revised to a long uncemented stem. In the uncemented group, 3 patients sustained 
dislocations of the prosthesis. One of these dislocations occurred after a fall, and the second 
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was found to be dislocated on the first post-operative radiograph in a patient with an intra-
operative peri-prosthetic fracture fixed with a plate and screws. This dislocation was treated 
with a change of the liner to an elevated rim. The third dislocation was caused by an 
undersized stem, which subsided and dislocated. This stem was revised to a cemented stem. 
One patient had a superficial infection, which was treated with antibiotics. 
Secondary endpoints 
Mortality  
 Four patients died during the study (2 in each group). No deaths occurred during the 
operation or within the first month postoperatively. Statistically or clinically relevant 
differences in the HHS and ADL were not observed between the groups throughout the 
study period. The mean PNRS was higher in the uncemented group during the first 3 
months, and it was higher in the cemented group at 12 and 24 months. None of the 
differences were statistically significant (Table 8). 
General complications  
Four thrombotic events occurred in the cemented group during the study period: 2 patients 
suffered pulmonary embolisms during the primary hospital admission, and 1 patient had a 
pulmonary embolism between the 12-month and 24-month follow-up examinations. All 
pulmonary embolisms were temporary and treated with warfarin for 6 months. All 3 
patients attended the 2-year follow-up visit. We found 1 deep-vein thrombosis at the 3-
month follow up. No thrombotic events were found in the uncemented group (mean 
difference=0.15; 95% CI, −0.004 to 0.31; p=0.06). At the 3-month follow up, 2 patients in 
each group had suffered heart failure. One patient in each group had a cerebral vascular 
lesion prior to the 24-month follow-up visit. One patient in the uncemented group suffered 
an acute myocardial infarction before the 24-month follow-up visit. The CRP and D-dimer 
results were similar in both groups (Table 9). Most patients in the study had some degree of 
heterotopic ossification. Table 10 shows the radiological outcomes. 
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Figure 10: Flow of the patients in study II. 
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Table 5: Baseline data for all patients included in the study. Values indicate the number of 
patients or the mean, with standard deviations or ranges in parentheses. 
 Cemented (n=35) Uncemented (n=34) 
Sex (n)   
Female 22 25 
Male 12 10 
Age, mean (SD) 72 (4) 73 (5) 
ASA (n) 
1-2 
3-4  
 
26 
9 
 
17 
17 
BMI 23 (17-38) 24 (20-34) 
Type of femur preoperatively (n)   
Dorr Type A 12 5 
Dorr Type B 19 27 
Dorr Type C 4 2 
 
 
 
Table 6: Operative data. Variables are presented as the mean, standard deviation and 95% 
confidence interval.  
Outcome measure Cemented 
(n=35) 
Uncemented 
(n=34) 
Mean difference 
Surgery time (min) 111 (24) 98 (20) 13 (2 to 24) 
Peri-operative bleeding (mL) 453 (241)  485 (287) -32 (-169 to 104) 
Change in systolic BP during 
stem insertion (mmHg) 
-4 (8) -3 (5) -1 (-5 to 3) 
Change in pulse oximetry (%) 0 (2) 0 (2) 0 (-1 to 1) 
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Table 7: Complications and reoperations. All complications and reoperations are counted; 
therefore, more than one complication or reoperation may apply for each hip. 
Complications Cemented group 
(n=35) 
Uncemented group 
(n=34) 
Dislocation  1 3 
Peri-prosthetic fracture intra-operative 0 3 
Late Peri-prosthetic fracture  0 1 
Superficial infection 0 1 
Unstable stem 0 1 
Total number of hip complications 1 9 
Number of patients with any complication 1 (3%) 7 (21%) 
Additional treatment*/reoperation   
Plate fixation because of intra-operative peri-
prosthetic fracture 
0 1 
Cerclage wires inserted because of intra-operative 
peri-prosthetic fracture 
0 2 
Closed reduction  1 1 
Open reduction 0 1 
Stem revision 0 3 
Total number of hips requiring additional 
treatment during the primary surgery 
0 (0%) 3 (9%) 
Total number of hips with any major reoperation 0 (0%) 4 (12%) 
* Extra resources during the primary surgery because of some complication 
No. (%) is presented 
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Table 8: Functional outcomes. Variables EQ-5D, HHS and PNRS are presented as the mean, 
standard deviation and 95% confidence interval. ADL is presented with proportion of patients 
with fully independent activities of daily living according to the treatment. 
 
  
Outcome measure Cemented Uncemented Mean difference (95% CI) 
EQ-5D 
Baseline 
At 3 months 
At 12 months 
At 24 months 
HHS 
Baseline 
At 3 months 
At 12 months 
At 24 months 
ADL 
Baseline 
At 3 months 
At 12 months 
At 24 months 
PNRS 
Baseline 
At 3 months 
At 12 months 
At 24 months 
 
0.8 (0.3) (n=35) 
0.7 (0.3) (n=34) 
0.8 (0.2) (n=33) 
0.7 (0.3) (n=30) 
 
93 (10) (n=35) 
73 (12) (n=34) 
79 (19) (n=34) 
80 (17) (n=34) 
 
   100% (35/35) 
    94% (32/34) 
    90% (30/33) 
    94% (29/31) 
 
0.3 (1.5) (n=35) 
2.2 (1.0) (n=34) 
2.1 (2.4) (n=32) 
2.1 (2.3) (n=31) 
 
0.8 (0.3) (n=32) 
0.7 (0.2) (n=30) 
0.8 (0.3) (n=29) 
0.8 (0.2) (n=26) 
 
91 (11) (n=32) 
72 (14) (n=31) 
82 (15) (n=31) 
81 (16) (n=30) 
 
100% (34/34) 
94% (29/31) 
93% (28/30) 
93% (26/28) 
 
0.6 (1.6) (n=32) 
3.0 (2.4) (n=30) 
1.1 (1.5) (n=29) 
1.3 (1.9) (n=2) 
 
-0.00 (-0.2 to 0.1) 
-0.00 (-0.2 to 0.1) 
-0.00 (-0.2 to 0.9) 
-0.03 (-0.2 to 0.1) 
 
2 (-3 to 7.1) 
1 (-6 to 7.2) 
 -3 (-11 to 5.7) 
-1 (-9 to 10) 
 
 
 
 
 
 
-0.3 (-1 to 0.4) 
-0.9 (-2 to 0.2) 
1 (-09 to 2) 
0.8 (-0.3 to 1.8) 
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Table 9: Serological markers. Variables are presented as the mean, standard deviation and 
95% confidence interval. 
Outcome measure Cemented 
(n=35) 
Uncemented 
(n=34) 
Mean difference 
(95% CI) 
D-dimer    
Preop 3.9 (3.2) (n=29) 3.4 (3) (n=27) 0.5 (-1.1 to 2.2) 
POD1* 0.7 (0.84) (n=31) 0.7 (.086) (n=31) 0.03 (-0.4 to 0.5) 
POD4* 1.4 (4.9) (n=25) 0.5 (0.18) (n=25) 0.9 (-1 to 2.8) 
At 3 months 0.8 (0.7) (n=23) 0.6 (0.3) (n=22) 0.25 (-0.9 to 0.6) 
CRP    
Preop 14 (28) (n=35) 29 (59) (n=33) -16 ( -38 to 8) 
POD1* 120 (61) (n=32) 122 (61) (n=31) -2 (-33 to 28) 
POD4* 
At 3 months 
202 (88) (n=28) 
10 (23) (n=26) 
235 (64) (n=27) 
5 (6) (n=24) 
-33 (-75 to 9) 
5 (-5- to 15) 
*POD: Post-operative day  
 
 
Table 10: Radiological outcomes. 
Heterotopic Ossification at the 
24-month follow up 
Cemented 
(n=33) 
Uncemented 
(n=28) 
Grade 0 4 4 
Grade 1 16 13 
Grade 2 8 4 
Grade 3 2 7 
Grade 4  3 0 
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STUDY III 
Patient flow and baseline data 
Between September 2009 and March 2016, 966 patients with displaced FNF were admitted to 
the Orthopaedic Department at Danderyd Hospital. Of these, 120 patients met the inclusion 
criteria and were recruited to participate in the study (Figure 11). The study group included 
90 women and 30 men with a mean age of 86 years (range, 80-94). 60 patients were 
randomized to the HA group and 60 were randomized to the THA group. All subjects 
received their allocated treatment except one subject who was allocated to THA but was 
operated with closed reduction and IF with 2 screws because of urosepsis. Regarding hip 
complications and reoperations, we could follow up all patients, including the 9 patients who 
refused to attend their clinical follow-up visits. The baseline data characteristics of the two 
groups are presented in Table 11, and differences are not observed with regard to sex, age, 
BMI and functional class according Charnley. However, two-thirds of the patients in the HA 
group presented ASA 3-4, whereas half of the patients in the THA group presented ASA 3-4. 
Operative data 
The mean surgery time was 22 minutes shorter in the HA group, and this difference was 
statistically significant (p=0.001). Significant differences in preoperative bleeding were not 
observed. Table 11 shows the operative data. 26 patients in the HA group and 23 patients in 
the THA group were operated with the CPT stem. The remaining patients were operated with 
the SP2 stem. 
Primary endpoints 
Differences in hip function or HRQoL were not observed between the groups up to one year 
after surgery (Table 12). The HHS significantly deteriorated in both groups, whereas the EQ-
5D scores deteriorated only in the THA group, although this deterioration was not statistically 
significant.  
Secondary endpoints 
Statistically significant differences were not observed in the prevalence of all hip-related 
complications and reoperations up to one year postoperatively. We found 4 complications in 
every group. In the HA group, one single dislocation and three deep peri-prosthetic infections 
were observed, whereas in the THA group, three superficial infections and one non-union 
were observed. The patient who was operated with closed reduction and IF developed non-
union and underwent a major reoperation with THA. Two of three patients in the HA group 
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who suffered deep peri-prosthetic infection were treated surgically, whereas the third was 
treated conservatively with antibiotics for three months. The surgical procedure was the one–
stage revision involving surgical debridement, removal of the prosthesis and re-cementing of 
a new implant. Table 13 shows the hip-related complications, reoperations and general 
complications during the study period. Differences in ADL and pain scores were not 
observed between the groups during the follow-up period. However, both of these scores 
deteriorated in both groups. No difference in mortality was found. Four patients, with 2 in 
each group, died during the study. No deaths occurred during surgery.  
Two patients in each group were bedridden or wheelchair bound at the one-year follow-up 
visit. The ability to regain their previous walking function was diminished over the duration 
of the study period, with 47% (26/55) and 42% (24/57) of the patients in the HA and THA 
group able to regain their previous walking function, respectively. The mean deterioration in 
walking distance was statistically significant in both groups, and differences were not 
observed between the groups. The mean deterioration in walking distance according to the 
HHS was -2.2 (CI 95% -3.2 to -1.3; p<0.001) in the HA group and -2.4 (CI 95% -3.4 to -1.5; 
p<0.001) in the THA group. 
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Figure 11: Flow of the patients in study III.  
 
  
Assessedd for eligibility 
(n=966) 
Randomized 
(n=120) 
Excluded (n=846) 
- Meeting exclusion criteria (n=487) 
- Declined to participate (n=135) 
- Lost in screening (n=224) 
- Allocated to THA(n=60) 
- Recieved THA (n=59) 
-Recieved IF (n=1) 
Allocated to HA (n=60) 
Recieved HA (n=60 
3 months (n=57) 
- Withdrew consent (n=2) 
- Deceased (n=1) 
 
12 months (n=56) 
- Withdrew consent (n=0) 
- Deceased (n=1) 
3 months (n=54) 
- Withdrew consent (n=5) 
- Deceased (n=1) 
 
12 months (n=50) 
- Withdrew consent (n=3) 
- Deceased (1) 
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Table 11: Baseline data for all patients included in study III. Values indicate the number of 
patients or the mean and standard deviation with percentages in parentheses  
 HA (n=60) THA (n=60) 
Sex (n)   
Female 45 45 
Male 15 15 
Age 86±4 85±4 
ASA   
1-2 20 30 
3-4 40 30 
BMI 25±4 24±4 
Functional class according to Charnley   
A 50 46 
B 4 9 
C 6 5 
Mobility: No walking aid or just one stick (%) 29 (48%) 30 (50%) 
Living condition   
Independent living 57 58 
Service buildings/senior housing 3 2 
Operative data   
Surgery time  77±19 99±25 
Bleeding 324±216 355±202 
Discharged to geriatric ward 52 53 
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Table 12: Differences in functional outcomes between the two groups during the study 
period. Variables are presented as the mean, standard deviation 95% confidence interval. 
ADL is presented with proportion of patients with fully independent activities of daily living 
according to the treatment. P-values were derived from Student´s T-test for Variables EQ-5D, 
HHS, and PNRS, and from Chi-Square test for ADL variable. 
 
 HA (n=60) THA (n=60) Mean difference 
(95% CI) 
P-value 
EQ-5D     
Baseline 0.67±0.34(n=59) 0.75±0.26(60) -0.08(-0.19 – 0.02) 0.135 
At 3 months 0.67±0.24(n=54) 0.65±0.26(57) 0.02(-0.07 – 0.11) 0.664 
At 12 months 0.66±0.27(n=50) 0.68±0.30(56) -0,0(-0.13 – 0.09) 0.711 
HHS     
Baseline 88±12(n=59) 89±10(60) -1 (-5 – 3) 0.648 
At 3 months 69±14(n=54) 70±13(57) -1 (-6 – 4) 0.718 
At 12 months 71±16(n=50) 74±16(56) -3(-9 – 3) 0.331 
PNRS     
Baseline 0.4±1.6(n=59) 0.38±1.3(60) -0.01(-0.54 – 0.52) 0.969 
At 3 months 2.3±1.9(n=54 1.9±1.7(57) 0.33(-0.35 – 1) 0.344 
At 12 months 1.6±1.8(n=50) 1.3±1.8(56) 0.31(-0.39 – 1) 0.310 
ADL     
Baseline 90%(53/59) 93%(56/60)  0.440 
At 3 months 69%(37/54) 68%(39/57)  0.447 
At 12 months 68%(34/50) 64% (36/56)  0.626 
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Table 13: Complications and reoperation up to 1 year after surgery. 
Complication HA (n=60) THA (n=60) 
Dislocation 1 0 
Superficial infection 0 3 
Deep peri-prosthetic infection 3 0 
Non-healing fracture 0 1 
Total number of hip complication  4 4 
Number of patients with any hip complication   
Reoperation   
Closed reduction 1 0 
Surgical debridement and one-stage revision 2 0 
Another major reoperation 0 1 
Total number of major reoperation 2 1 
General complications   
Pneumonia 7 4 
Pulmonary embolism 1 1 
Myocardial infarct 1 2 
Cerebral vascular lesion (CVL) 3 6 
Acute kidney failure 0 1 
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STUDY IV 
Patient flow and baseline data 
A total of 966 patients were screened during the inclusion period, and 160 were recruited to 
participate in the study (Figure 12). The characteristics of the groups and the surgical data 
were similar at baseline, although the patients in the cognitive dysfunction group had lower 
functional outcome scores, a lower HRQoL and a shorter walking distance at baseline than 
the control group. Because the majority of patients in the cognitive dysfunction group were in 
nursing homes with staff available around the clock prior to the fracture, they were sent back 
to their nursing home. Only 38% of the patients in the cognitive dysfunction group received 
rehabilitation at a geriatric ward after surgery (Table 14). 
Hip complications and reoperations: 
During the study period, twelve patients (8%) suffered at least one hip-related 
complication. Although the overall major reoperation rate was slightly higher in the 
cognitive dysfunction group than in the controls (6% versus 3%), this difference failed to 
reach statistical significance (Table 15). The results were unchanged after using of 
competing risk analysis. Two patients in the cognitive dysfunction group with recurrent 
dislocation were treated twice with closed reduction before revision surgery with a THA. 
Three peri-prosthetic fractures occurred in the cognitive dysfunction group in patients who 
had received a tapered CPT stem. All three were treated with open reduction and IF. Four 
patients, with three in the control group and one in the cognitive dysfunction group, 
suffered peri-prosthetic joint infections. Three were treated surgically, and one patient in 
the control group was treated conservatively with an antibiotic for three months. The 
surgical treatment was a one-stage revision involving surgical debridement, prosthesis 
removal and re-cementing a new implant.  
Walking ability 
At the three-month follow-up after arthroplasty, 13% (10/75) of the surviving patients in the 
cognitive dysfunction group and 2% (1/54) in the control group were either confined to bed 
or in a wheelchair (p=0.024, Fisher’s exact test). At one year, the proportion had increased to 
31% (19/61) in the cognitive dysfunction group and 5% (2/50) in the control group (OR: 
10.9; 95% CI: 2 to 49; p<0.001, Fisher’s exact test). The capacity to return to preoperative 
walking ability was diminished over the study duration; 51% (37/73) of the patients in the 
cognitive dysfunction group and 47% (26/55) of patients in the control group returned to their 
previous walking ability (p=0.86, Fisher’s exact test). Those patients in the cognitive 
dysfunction group who did not receive geriatric rehabilitation were almost nine times more 
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likely to be confined to a wheelchair or bedridden despite having no pain in the involved hip 
(OR: 8.8; 95% CI: 2.3 to 32.9; Table 16). The results were unchanged after the regression 
analysis and sensitivity analysis using multiple imputations. The geriatric rehabilitation 
programme and the presence of cognitive dysfunction (to a lesser extent) seemed to be the 
only two factors that influenced the loss of walking ability (Table 16). 
Mortality 
No sudden death related to cement implantation syndrome occurred during surgery. The 
cognitive dysfunction group had a higher mortality rate than the control group at one year at 
35% (n=35) versus 4% (n=2), respectively.  
Functional outcomes   
All functional outcomes were better in the control group than the cognitive dysfunction group 
at baseline. The mean HRQoL remained unchanged from baseline throughout the study 
period in both groups, and the largest decline in HHS at one year occurred in the control 
group (Table 17, Figure 13). The mean PNRS increased significantly in the control group, 
and the initial significant difference between the groups was reduced during the study period 
(Table 17). The ADL deteriorated in both groups, and the initial difference in ADL between 
the two groups was maintained throughout the study period (Table 17). Those patients in the 
cognitive dysfunction group who did not receive geriatric rehabilitation had worse outcomes 
for HRQoL and hip function (Figure 14). The linear regression analysis shows that the 
presence of cognitive dysfunction, the status of geriatric rehabilitation and the pre-fracture 
value were the only factors that affected the HRQoL and hip function (Table 17).  
Adverse events 
Six patients (11%) in the control group and seven (7%) in the cognitive dysfunction group 
suffered pneumonia and required treatment during the study period. One patient (2%) in the 
control group and two (2%) in the cognitive dysfunction group suffered a pulmonary 
embolism and were treated with warfarin for six months. One patient in the control group 
suffered a myocardial heart infarct. During the study period, three (5%) patients in the control 
group and five (5%) in the cognitive dysfunction group suffered cerebral vascular lesion 
(CVL), and one patient in the cognitive dysfunction group had a DVT. No other general 
complications were identified during the study period.  
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Figure 12: Flow of the patients in study IV 
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 Table 14: Baseline data for all patients included in study IV. Numerical variables are 
presented as the mean and standard deviation, and categorical variables are presented as 
numbers with percentages. 
  
 Control group 
(n = 60) 
Cognitive dysfunction group 
(n = 100) 
Sex (n)   
Female 45 72 
Male 15 28 
   
Age (years) 86 ± 4  86 ± 6  
Cognitive status (SPMSQ)   
Normal (8-10) 60 0 
Mild-moderate dysfunction (3-7) 0 10 
Severe cognitive dysfunction (0-2) 0 90 
ASA (n)   
1-2 20 24 
3-4 40 76 
BMI (kg/m2) 25 ± 4 23 ± 4 
   
Functional class according to Charnley (n)   
A 50 77 
B 4 18 
C 6 5 
   
Living conditions (n) 
  
Independent living  
57 34 
Nursing home 3 66 
   
Surgery time (min) 77 ± 18 82 ± 22 
   
Bleeding (mL) 329 ± 214 311 ± 140 
   
Discharged to geriatric ward (n) 53 (88%) 38 (38%) 
   
Walking distance according to Harris Hip 
Score (Question 4; n) 
  
 Less than 0.5 km  13 (22%) 59 (61%) 
 0.5-1 km  8 (14%) 22 (23%) 
 1-2 km  5 (8%) 10 (10%) 
 More than 2 km  33 (56%) 6 (6%) 
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Table 15: Complications and reoperation up to 1 year after surgery. 
Complications                                                             Control group 
(n=60) 
Cognitive dysfunction group 
(n=100) 
Dislocation  1 2 
Peri-prosthetic fracture  0 3 
Superficial infection 0 2 
Deep infection 3 1 
Total number of hip 
complication 
4 8 
Number of patients with any hip 4 (7%) 8 (8%) 
Complication   
Reoperation        
Closed reduction of dislocation 1 2 
Revision to total hip 
arthroplasty 
0 2 
Open reduction and internal of  0 3 
Peri-prosthetic fracture   
Surgical debridement and one- 2 1 
stage revision   
Total number of patients  3 6 
who underwent at least one 
reoperation 
  
Total number of any 
reoperation 
3 10 
Total number of major 
reoperation*  
2 (3%) 6 (6%) 
 
Complications: OR, 1.21 (95% CI, 0.35 to 4.2), p=1.00 
Major reoperation: OR, 1.85 (95% CI, 0.36- to 9.5), p=0.71 
Major reoperations were defined as the revision of total hip arthroplasty, open reduction 
and internal fixation and surgical debridement with one-stage revision   
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Table 16: Crude, adjusted and multiple imputation logistic and linear regression for outcomes 
at the 1-year follow-up visit. In the logistic regression model, the number of patients at risk 
and events at 1 year are presented for dichotomous variables. The models are adjusted by 
group, age, sex, and whether the patients were admitted to geriatric rehabilitation after 
surgery. All outcomes were also adjusted by their pre-fracture status, i.e., the pre-fracture 
HHS was used as a co-variate in the model for the Harris hip score at 1 year. 
 
    Crude  Adjusted   Adjusted with MI 
Variable n Event  Est. 95% CI  Est. 95% CI P-
value 
 Est. 95% CI 
             
Logistic regression (odds ratio)  
Confined to wheelchair/unable to walk 1 year         
Group             
Controls 50 2 (4%)  Ref.  Ref.   Ref. 
Cognitive dysfunction 61 19 (31%)  10.1 2.4 – 49.3  4.2 0.7 – 23.0 0.1  3.3 0.5 – 8.1 
Geriatric rehab             
Yes 73 4 (6%)  Ref.  Ref.   Ref. 
No 38 17 (45%)  14.0 4.2 – 46.1  8.8 2.3 – 32.9 0.001  4.1 1.2 – 14.4 
Sex             
Female 87 17 (20%)  Ref.  Ref.   Ref. 
Male 24 4 (17%)  0.8 0.2 – 2.7  2.4 0.5 – 12.2 0.3  1.6 0.1 – 16.4 
Pre-fracture walking ability   0.8 0.7 – 0.9  0.9 0.7 – 1.1 0.2    
Age    1.0 0.9 – 1.1  0.9 0.8 – 1.1 0.3  0.9 0.9 – 1.1 
             
Linear regression (units) 
      Health-related quality of life (EQ-5D) index         
Group             
Controls              
Cognitive dysfunction    -0.40 -0.51 – -0.29  -0.18 -0.30 – -0.06 0.005  -0.19 -0.30 – -0.07 
Geriatric rehab             
No    Ref.  Ref.    Ref.  
Yes    0.42 0.31 – 0.55  0.25 0.13 – 0.37 < 0.001  0.25 0.11 – 0.38 
Sex             
Female    Ref.   Ref.    Ref.  
Male    -0.05 -0.22 – 0.11  0.10 -0.02 – 0.22 0.11  0.12 0.25 – 0.42 
Pre-fracture EQ-5D    0.57 0.42 – 0.73  0.32 0.16 – 0.49 < 0.001  0.30 0.08 – 0.51 
Age    -0.01 -0.02 – 0.01  -0.01 -0.02 – 0.01 0.2  -0.01 -0.02 – 0.01 
              Hip function (HHS)         
Group             
Controls    Ref.  Ref.   Ref. 
Cognitive dysfunction    -2.5 -8.5 – 3.5  6.2 -0.2 – 12.5 0.06  4.7 -1.3 – 10.7 
Geriatric rehab             
No    Ref.  Ref.   Ref. 
Yes    11.2 5.3 – 17.1  11.8 5.4 – 18.3 < 0.001  7.7 1.4 – 13.9 
Sex           
Female    Ref.  Ref.   Ref. 
Male    -4.2 -11.4 – 3.0  -0.4 -7.2 – 6.4 0.9  -1.3 -8.4 – 5.8 
Pre-fracture HHS    0.4 0.2 – 0.5  0.3 0.2 – 0.5 0.001  0.3 0.1 – 0.5 
Age    -0.3 -1.0 – 0.3  -0.1 -0.6 – 0.5 0.9  -0.1 -0.9 – 0.6 
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Table 17: Functional outcomes during the study period. Variables are presented as the 
mean, standard deviation 95% confidence interval. ADL is presented with proportion of 
patients with fully independent activities of daily living according to the treatment. P-values 
were derived from Student´s T-test for Variables EQ-5D, HHS, and PNRS, and from Chi-
Square test for ADL variable.  
Functional 
outcome 
Control group 
(n=60) 
Cognitive dysfunction 
group (n=100) 
Mean difference 
(95% CI) 
P-
value 
EQ-5D     
Baseline 0.67±0.34 (n=59) 0.27±0.28 (n=96) 0.4 (0.28-0.48) <0.001 
At 3 months 0.67±0.24 (n=54) 0.24±0.3 (n=71) 0.43 (0.33-0.53) <0.001 
At 12 months 0.66±0.27 (n=50) 0.25±0.32 (n=57) 0.41 (0.3-0.53) <0.001 
HHS     
Baseline 88±12 (n=59) 78±15.7 (n=97) 10 (5 - 14) <0.001 
At 3 months 69±14 (n=54) 61±17 (n=76) 8 (2-13) <0.007 
At 12 months 71±16 (n=50) 69±16 (n=61) 2 (-4-8) 0.528 
PNRS     
Baseline 0.4±1.6 (n=59) 1.3±2.2 (n=93) -0.9 (-1.5--0.3) 0.004 
At 3 months 2.3±1.9 (n=54) 2.1±2.2 (n=69) 0.2 (-0.6-0.9) 0.711 
At 12 months 1.6±1.8 (n=50) 1.3±2 (n=57) 0.3 (-0.5-1) 0.46 
ADL     
Baseline 90% (53/59) 13% (13/100)   <0.001 
At 3 months 69% (37/54) 7% (5/73)  <0.001 
At 12 months 68% (34/50) 7% (4/58)  <0.001 
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Figure 13. 
Line graph illustrating the mean (and 95% CI) hip function, health-related quality of life and 
pain scores during the study. Solid lines represent the control group, and dotted lines are the 
cognitive dysfunction group. HHS=Harris hip score. PNRS=Pain numerical rating scale. EQ-
5D=European Quality of life five dimensions. 
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Figure 14. 
Line graph illustrating the mean (and 95% confidence interval) hip function and health-
related quality of life for patients in the cognitive dysfunction group who received and did not 
receive structured geriatric rehabilitation after surgery. HHS=Harris hip score. EQ-
5D=European Quality of life five dimensions. 
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GENERAL DISCUSSION 
The overall purpose of this thesis was to define the optimal treatment for elderly patients with 
a displaced FNF with consideration of age, functional demands and cognitive function by 
investigating the clinical outcomes, which are based on the functional and surgical outcomes, 
after treatment of a displaced FNF with IF and hip arthroplasty. The results presented in this 
thesis indicate that cemented THA provides better hip function and significantly fewer 
complications and reoperations than IF in a group of healthy elderly patients with a displaced 
FNF over a long-term follow-up period of seventeen years. The results also indicate the 
occurrence of more complications with uncemented than with cemented stems in THA for a 
displaced FNF in elderly patients in the short-term follow up. The recent shift towards using 
cemented HA in elderly patients with a displaced FNF is reflected in the findings in this 
thesis, especially in studies III and IV.   
LONG-TERM RESULTS OF TOTAL HIP ARTHROPLASTY 
During the first phase after the introduction of arthroplasty as a treatment option for displaced 
FNFs, the supporters of IF argued that the new method might lead to the need for additional 
revisions of arthroplasty over the long term because of aseptic loosening and peri-prosthetic 
fractures.  
In study I, we evaluated the outcomes at eleven and seventeen years after enrolment, thus 
providing long-term data for fracture treatment that are rarely available, particularly in a 
randomized study design. The basic conclusion was that in active patients above 65 years of 
age, THA is superior to IF. This conclusion would have been ground-breaking and 
controversial in the early 1990s when this study began enrolling patients. This conclusion is 
now well known and accepted based on many studies published during the prolonged follow-
up period of this study. Despite the early follow-up evidence that THA has fewer 
complications, clinicians remained concerned about this treatment because of the possibility 
of an increased incidence of late failure as a result of loosening and peri-prosthetic fracture 
compared with successful IF with a preserved native femoral head. This study addresses this 
concern by clearly showing that the high early failure rate after IF is not completely offset by 
late failures after THA and provides further strong evidence that THA is the best and most 
long-lasting option for the treatment of FNF in patients over sixty-five years of age with 
excellent pre-existing hip function. During the prolonged follow-up period of this study, three 
log-term follow-up studies have been published comparing THA with IF [44, 49, 56]. These 
studies included a greater number of patients than that in our study. Ravikumar and Marsh 
[49] evaluated hip function using the HHS and found that THR yielded a superior result over 
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IF at thirteen years. In a 10-years follow-up study, Leonardsson et al. [44] concluded that 
primary replacement provided reliable long-term results in patients with displaced fracture of 
the femoral neck. Johansson [56] did not use any patient-reported outcomes (PROs). In terms 
of complications and revision surgery, Ravikumar and Marsh, Leonardsson et al. and 
Johansson reported revision rates of 6.8%, 8.8%, and 5.0% for THA and 33%, 46.6% and 
55% for IF, respectively. These results are consistent with our findings. The secondary 
outcome measurements favoured the group treated with THA, although a difference in 
mortality was not observed between the groups. Patients who were managed with THA also 
had less pain in the involved hip over the long term.  
Since the early 1990s when this study was initiated, many improvements have been 
observed in total hip replacement that have increased the implant life span and reduced the 
risk of complications and need for revision surgery. The posterior lateral approach was used 
in this study without capsular repair. The posterior lateral approach has been linked to an 
increased risk for dislocation and revision surgery compared with the direct lateral 
approach [68, 69, 106-109]. The use of larger femoral head sizes (32-36 mm) has been 
shown to reduce the need for revision surgery because of dislocation [106]. A 28-mm head 
was used in this study. 
The cemented, straight, polished and tapered femoral stem of the titanium alloy used in this 
study is a less-than-optimal cemented femoral component. Studies have shown superior 
results with a reduced incidence of aseptic loosening for cobalt-chromium stems compared 
with that of titanium alloy stems when used with bone cement [139, 140]. Two recent 
studies examining the prevalence of peri-prosthetic fractures in elderly patients who 
received stems similar to those used in our study indicated an increased risk of peri-
prosthetic fracture [141, 142]. The cemented, straight, polished and tapered femoral stem of 
the titanium alloy used in this study is no longer used at our institution. However, the 
incidence of aseptic loosening of the prosthesis or peri-prosthetic fracture in this study did 
not exceed the rates in previously reported long-term studies of patients with osteoarthritis 
[143, 144]. The above-mentioned improvements have most certainly increased the 
differences in PRO and reoperation rates between primary THA and IF. The age limit of 65 
years was used to differentiate young and elderly patient as well as the patients who 
underwent IF or THA in study I. This consideration was implemented in the early 1990s 
when study I began enrolling patients. As the longevity and level of activity of today’s 
elderly increases, it is advisable to raise the age limit to 70 years. 
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TREATMENT CHOICE 
Cemented or uncemented implants 
The uncemented prosthesis was used earlier in time than the cemented prosthesis (Moore 
1952). Previous comparisons in the treatment of FNFs have almost consistently favoured 
cemented fixation, which is mainly because of the better mobility, lower rates of peri-
prosthetic fractures and revision, and reduced thigh pain, without increasing post-operative 
complications [81, 82]. Such results are based on studies comparing non-modular old-
generation prostheses, such as Austin Moore and Thompson hip implants. Because good 
results have been achieved using modern hydroxyapatite-coated femoral stems in younger 
patients with osteoarthritis, the concept of inserting an uncemented femoral component in 
patients with displaced FNF has become popular for many surgeons [145]. The concern 
regarding intra-operative death caused by embolization of fat and bone marrow contents 
associated with cementation (BCIS) [146] is the principal argument for using uncemented 
implants. 
 In study II, we compared the effectiveness and safety between a modern cemented and a 
modern uncemented hydroxyapatite-coated femoral stem in patients 65–79 years of age 
who were treated with THA for displaced FNF. We found a higher risk of peri-prosthetic 
fractures and reoperations with the use of a reverse-hybrid THA than with the use of a 
cemented THA. Our trial did not have the statistical power to address the possible adverse 
effects of cement, and we did not find any indications of differences in mortality between 
the groups related to cementing. However, all thrombotic events occurred in the cemented 
group. The incidence of serious cement-related complications has been reported to be low 
[86], and a trial examining this would require several thousand patients. Despite this 
challenge, reports have indicated that peri-operative cardiovascular disturbances are more 
frequent in elderly patients with hip fracture when cemented rather than uncemented stems 
are used [147]. Previous investigations of outcomes after modern cemented and 
uncemented fracture-related arthroplasties are sparse, and several of the earlier trials are 
either of poor methodological quality or assess implants that are no longer frequently used 
[70, 148-150]. 
When we started this study, in addition to a pilot study in our clinic, on a modern 
hydroxyapatite-coated uncemented stem indicated that the uncemented stem could be used 
for elderly patients with osteoporotic fractures of the femoral neck without increasing the 
complication rate [84], only 12-month results were available from a RCT comparing HA 
using a modern modular cemented stem and HA using an uncemented hydroxyapatite-coated 
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stem for the treatment of FNF [83], and they did not show differences between the groups 
regarding complications, including peri-prosthetic fracture. Therefore, we found that it was 
justified to continue with this study. During the course of the study, results from six RCTs 
and one pilot study using modern cemented and uncemented stems have been reported. These 
studies detected few differences regarding function and HRQoL between the groups. Four 
studies with short-term results supported the use of cemented implants because of higher 
early implant-related complication rates in the uncemented group, which were mostly 
because of intra-operative peri-prosthetic fractures [151-154], whereas one RCT [155] 
showed no differences between the groups. For the late peri-prosthetic fractures, evidence 
from the Swedish Hip Arthroplasty Register [68, 156], from a 5-year follow up of a RCT 
[157] and a pilot study [158] indicated that uncemented stems constitute a risk factor for 
such complications in the long term. Data from the Norwegian Hip Fracture Register at the 
five-year follow up showed that uncemented HA had a 2.1-time increased risk for revision 
compared with cemented prostheses [159]. A Finnish database study found that uncemented 
HA was associated with more frequent mechanical complications and reoperations [160].   
In study II, no difference in mortality between the groups was found. Neither RCT [83, 
151-155, 157] showed any differences in mortality between patients treated with cemented 
or uncemented stems, which may have been because the study groups were underpowered 
to evaluate mortality. 
A study based on the Australian Orthopaedic Association National Joint Replacement 
Registry showed a high risk of death in patients with cemented implants on the first post-
operative day. However, the mortality risk was higher between the first week and first year 
post-fracture in the uncemented group [161]. One reason for the reversion of the early 
increased mortality risk after cemented HA could be that the patients with uncemented 
implants had more reoperations and thus ran the risk of new complications and death as a 
consequence of repeated surgery. 
An analysis of the Norwegian Hip Fracture Register also found a higher risk of death on the 
day of surgery and the first post-operative day in patients who received cemented HA, 
although after day two, the mortality rate was equivalent [162]. A Finnish database study 
also observed higher mortality in the cemented group until day 4 after surgery [160]. The 
National Patient Safety Agency in the United Kingdom in 2009 highlighted the risk of 
using bone cement in patients with hip fracture and encouraged the use of mitigation 
measures, including patient assessments and anaesthetic and surgical techniques [163]  
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However, a subsequent study from the National Hip Fracture Database in the United 
Kingdom showed no increase in peri-operative mortality as a result of cementing of the 
femoral component in patients with hip fracture [164]. Concise guidelines have been 
recently published in the United Kingdom after a national collaboration to advise 
anaesthetists and surgeons on the measures for reducing the risk of BCIS [165]. The risk of 
BCIS can be reduced by many measures, including the identification of patients at risk (e.g., 
the presence of comorbidities, including cardiovascular and respiratory disease is well 
documented [86, 166-169]), modified anaesthetic techniques [170] and the use of a 
pressurized lavage and suction catheter to reduce the embolic load and the intramedullary 
pressure during insertion of the cement [86, 171]. A reduction in intramedullary pressure has 
been reported to lead to a three-fold reduction in the rate of intra-operative mortality [86]. If 
the canal is adequately cleaned and the patient is properly prepared and monitored during 
the procedure, pressurization of the cement appears to confer no disadvantage in terms of 
risk and improves fixation of the femoral component [172]. 
The risk of intra- and peri-operative death, which is low [86, 90], must be weighed against the 
risk of peri-prosthetic fracture and reoperations. A second fracture and subsequent surgical 
procedure represent serious setbacks for elderly patients [173, 174]. 
Based on our results and those of others, we do not recommend the use of uncemented stems 
for the treatment of displaced FNF in elderly patients. For patients with high risk factors for 
intra- and peri-operative death, a discussion with the anaesthesiologist must occur. If the risk 
for intra-and peri-operative death is assessed to be very high, a suitable uncemented stem may 
be used as an exception to avoid inevitable death. Because the studies that have shown 
high intra-operative and early post-operative complications have used a direct anterior 
approach, which was mentioned in the discussion section for study II (see the discussion of 
study II), I recommend a posterior approach when using an uncemented stem. 
Total hip arthroplasty or hemiarthroplasty 
The aim of any surgical procedure for elderly patients with a displaced FNF is to return the 
patient to their previous functional status as soon as possible or provide a satisfactory 
functional status with minimal morbidity and minimal risk for re-surgery. Surgeons favouring 
THA over HA rely on the tendency for improved hip function and quality of life. In study III 
in this thesis, differences between the groups in favour of the HA group were not observed 
except the operation time. The absence of better HRQoL and functional outcomes in the THA 
group in study III compared with that of other studies [45, 72-76] may be explained by the 
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older age, lower mobility and limited demands for patients in study III compared with the 
healthy and relatively active patients in those studies.  
Several reports have suggested that a higher risk of dislocation occurs with THA [71, 81, 175, 
176], whereas others have found similar risks for both HA and THA [45, 74]. This 
inconsistency may be influenced by other factors, such as the surgical approach. The 
posterior lateral approach is linked to an increased risk of reoperation because of prosthetic 
dislocation in patients treated for osteoarthritis and FNF [105, 106]. The direct lateral 
approach has been proven to reduce the dislocation rate after hip arthroplasty compared 
with the posterior lateral approach [68, 69, 107, 108]. Dislocation was not observed in the 
THA group in study IV where the direct lateral approach was used. However, in study I in 
this thesis and in study [71], the posterior lateral approach was used.   
The long-term wear of acetabular cartilage and the subsequent need for conversion of HAs to 
THAs is another reason why THA should be used in lucid healthy active elderly patients [73]. 
In study III, radiological measurements of erosion of the acetabular cartilage in patients 
treated with HA was not performed because we believe that 1 year is a short time for erosion 
to occur. We did not identify any erosion in the HA group because of increased pain in any 
hip during the one-year follow-up examination. This result is inconsistent with the study by 
Baker et al. [73], who found significantly lower hip function and a shorter self-reported 
walking distance in the HA group than the THA group. At the 3-year follow up, 66% (20/32) 
of patients in the HA group had radiographic evidence of acetabular erosion. Only two hips 
were revised to THA, and three additional hips had acetabular erosion that was sufficiently 
severe to indicate revision. The inclusion of only healthy, relatively younger (mean age of 75 
years) active patients with good walking ability may have contributed to the higher rate of 
acetabular erosion and the poor outcomes following HA. 
In a four-year follow up of a RCT, Hedbeck et al. [74] found 14% acetabular erosion at grade 
1 (narrowing of the articular cartilage, with no bone erosion) in the bipolar HA group. 
However, significant differences in pain or functioning were not observed between the 
patients with and without erosion, and no revision to THA was recorded. The mean age in the 
study by Hedbeck was 80 years when the patients were included. The absence of revision in 
the HA group in our study and in the study by Hedbeck may be attributed to the limited 
activity in patients above 80 years of age and insufficient time for the appearance of clinical 
erosion.  
  63 
In accordance with our results, many short-, intermediate- and long-term follow-up trials did 
not show significant differences between HA and THA and did not recommend THA for 
elderly patients with a displaced fracture of the femoral neck [70, 71, 76, 177, 178] 
In conclusion, over a short-term follow-up period, differences were not observed in the 
outcomes after treatment with either HA or THA in elderly patients with a mean age of 85.5 
years with a displaced FNF. I recommend HA for patients aged 80 years and above with a 
displaced femoral fracture.  
Our four-year follow-up period of this study will elucidate whether elderly patient above 80 
years of age with a displaced FNF will show greater benefits from THA relative to HA. 
Hemiarthroplasty for patients with cognitive dysfunction 
Historically, patients with cognitive dysfunction were regarded as contraindicated for 
arthroplasty because of the high risk of complications, such as infection, dislocation, and peri-
prosthetic fracture, and the high rate of mortality and general complications [17, 48, 58, 59, 
93, 94]. In addition, these patients may feel better in their own environment and will not 
receive benefits from rehabilitation. Therefore, these patients are discharged early to their 
own accommodation without any rehabilitation. Because IF is a simple surgical procedure 
that presents less trauma and is less demanding than arthroplasty procedures and because of 
the above-mentioned factors, many surgeons prefer this procedure instead of arthroplasty for 
this patient group. 
 The results for patients with FNF and cognitive dysfunction treated with HA have been 
sparsely investigated, and limited evidence is available for the effect of post-operative 
rehabilitation in this subpopulation; moreover, whether the results differ in comparison with 
patients without cognitive dysfunction is unclear. In study IV in this thesis, patients with and 
without cognitive dysfunction who received cemented HA using a direct lateral approach 
after displaced FNF were examined, and we found a slightly higher but not statistically 
significant prevalence of hip-related complications and reoperations in the cognitive 
dysfunction group. Changes in the EQ-5D were not observed over time. A higher rate of 
mortality and a higher prevalence of being unable to walk were observed in the cognitive 
dysfunction group than in the control group; however, the capacity to return to previous 
walking ability was poor in both groups. The cognitive dysfunction patients who did not 
receive geriatric rehabilitation had a worse patient-reported outcome and were almost nine 
times more likely to be confined to a wheelchair or bedridden than those who received 
geriatric rehabilitation.  
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The findings of this study regarding hip-related complications and reoperation are 
inconsistent with previous findings showing that this patients group has a significantly higher 
risk for complications. In a subgroup analysis, Johansson et al. [48] found that patients with 
cognitive dysfunction who received THA had a dislocation rate of 32% while patients with 
normal cognitive function who received THA had a dislocation rate of 12%. However, the 
posterior lateral approach, which is linked to an increased risk of reoperation because of 
prosthetic dislocation in patients treated for osteoarthritis and FNF [105, 106], was used in 
this study. In addition, the study had a limited number of patients with cognitive dysfunction 
who were received THA (22 patients). However, the use of THA in elderly patients with 
FNF, even those with normal cognitive function, is still debated, and until now, many RCTs 
[70, 71, 76, 177, 178] have not recommended THA for elderly patients with FNF. Therefore, 
patients with cognitive dysfunction who usually have limited activity and high mortality after 
hip fracture operation are not eligible for an extensive surgical procedure, such as THA. 
Two previous RCTs [58, 59] conducted in patients with cognitive dysfunction reported a 
lower HRQoL and higher rate of reoperations in the HA group than in the IF group. The 
prevalence of being unable to walk was high (65%) in both studies, regardless of the surgical 
procedure. The authors in both studies did not recommend HA for patients with cognitive 
dysfunction. However, the prosthesis used in both studies was non-modular and older 
generation and is now outdated. In addition, the sample size in both studies may not have 
been sufficiently large.   
The rate of hip-related complications and reoperations in the cognitive dysfunction group in 
study IV in this thesis was markedly lower than that of patients who received THA and HA in 
previous analyses [48, 58, 59] and slightly higher than that of patients without cognitive 
dysfunction, but this latter difference was not statistically significant. 
The deterioration in HRQoL and functional outcomes in study IV did not differ between 
patients with or without cognitive dysfunction. The incidence of being unable to walk in 
study IV was 31% in the cognitive function group and 65% in previous studies [58, 59], 
which may reflect the lower rate of complications and reoperations in our study and the effect 
of rehabilitation because 38% of patients with cognitive dysfunction were discharged to a 
geriatric ward. 
The high incidence of being unable to walk among patients with cognitive dysfunction likely 
reflects the natural process of dementia and cognitive impairment or the difficulty 
assimilating rehabilitation regimes in these patients. The high incidence could also indicate a 
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lack of rehabilitation resources for this patient group. Many patients with dementia or 
cognitive dysfunction live in nursing homes and often become discharged early from the 
hospital without receiving adequate rehabilitation. In our study, patients with cognitive 
dysfunction who did not receive geriatric rehabilitation had worse outcomes for HRQoL and 
hip function and were almost nine times more likely to be confined to a wheelchair or 
bedridden despite not having pain in the involved hip than those patients in the same group 
who received adequate rehabilitation. This finding confirms the results of other studies [179-
182] showing that patients with cognitive dysfunction can benefit from participation in 
rehabilitation programmes and regain their pre-fracture function after rehabilitation. 
Surgeons should be aware that the lack of structured rehabilitation after surgery leads to 
significant deterioration in walking ability regardless of a mechanically well-functioning 
prosthetic joint.  
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IMPLICATIONS FOR FUTURE RESEARCH 
 
• The results of study I show that THA is the treatment of choice for a displaced FNF in 
healthy and lucid elderly patients with good hip function preoperatively. The posterior 
lateral approach was used in this study, and it is still the most common approach in 
hip arthroplasty. This approach, which was used in study 1, is linked to an increased 
risk of dislocation rate after FNF compared with the direct lateral approach, which 
was used in studies II and III. However, the direct lateral approach is more 
traumatic and associated with post-operative limping. Limping may not be 
important problem in elderly patients with limited walking ability, although it may 
represent a problem in younger and more active patients. Dual mobility cups have 
showed promising results for decreasing the frequency of dislocation [183]. It would 
be interesting to perform a multicentre RCT for FNF patients to compare the direct 
lateral approach using the ordinary cup with the posterior lateral approach using a 
dual mobility cup in terms of complications, reoperations, HRQoL and hip function.  
• The use of bone cement in the elderly and frail populations can cause serious 
cardiopulmonary complications and sudden death during cementation or the early 
peri-operative period. In study II, we found a higher risk of peri-prosthetic fractures 
and reoperations with the use of uncemented stem in patients with FNF; therefore, the 
uncemented stem was not recommend for patients with FNF. However, for frail 
patients with a higher risk for bone implantation syndrome, a modern uncemented 
stem may be indicated to avoid inevitable death. Future research should investigate 
the advantages and disadvantages of using a modern uncemented prosthesis in 
patients with a higher risk for BCIS compared with a cemented stem using mitigation 
measures to reduce the risk for BCIS.  
• HA is the most common procedure for patients with a displaced FNF. In Sweden, 
64% of patients with a displaced FNF receive HA. When we started study III, limited 
evidence was available showing that THA produced better HRQoL or functional 
outcomes than HA in elderly patients with a displaced FNF. As the study progressed, 
many RCTs with short, intermediate and long follow-up periods showed no 
differences between THA and HA. This inconsistency may be influenced by other 
factors, such as the surgical approach and patient age, activity and mental status. 
Because of this inconsistency between studies, I recommend further multicentre 
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RCTs with a large sample size that consider the surgical approach and patient age, 
activity and mental status. 
• The results of study IV show that cemented HA with a direct lateral approach is a 
good option for elderly patients with a displaced FNF and cognitive dysfunction. The 
results are generally consistent with those of patients without cognitive dysfunction 
regarding the complications, reoperations, HRQoL and hip function. This study also 
showed that patients with cognitive dysfunction can benefit from participation in 
rehabilitation programmes and can regain their pre-fracture function after 
rehabilitation. This finding is inconsistent with previous assumptions. However, only 
38% of patients in study IV were discharged to a geriatric ward. Because of the 
positive findings between rehabilitation and opportunities to restore walking ability in 
this patient group, a large cohort study to further address this finding is justified.   
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MAIN CONCLUSIONS OF THIS THESIS  
• THA is the treatment of choice for a displaced FNF in healthy and lucid elderly 
patients with good hip function preoperatively; 
• Uncemented femoral stems should be avoided in patients older than 65 years with a 
displaced FNF; 
• THA yields no benefit compared with HA in octogenarians treated for a displaced 
FNF; 
• HA is a safe option as a treatment for displaced FNF in patients with dementia or 
cognitive dysfunction
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APPENDIX 
 
SPMSQ - Short Portable Mental State Questionnaire 
 
Fråga:  
1. Vad är det för datum i dag? Rätt/Fel  
2. Vilken veckodag är det? Rätt/Fel  
3. Vad heter detta sjukhus? Rätt/Fel  
4. Vilken adress har du? Rätt/Fel  
5. Hur gammal är du? Rätt/Fel  
6. När föddes Du (år, månad, dag)? Rätt/Fel  
7. Vad heter nuvarande statsminister? Rätt/Fel  
8. Vad hette den förre statsministern? Rätt/Fel  
9. Vad var din mors flicknamn? Rätt/Fel  
10. Dra 3 från 20 och fortsätt hela vägen ner. Antal rätta svar. Rätt/Fel 
 
 
 
Function classification according Charnley  
(A) - En höft sjuk - för övrigt väsentligen frisk 
(B) - Bilat höfter sjuka - för övrigt väsentligen frisk 
 
(C) -Flera leder påverkade/annat gånghandikapp 
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Harris Hip Score 
 
1. Beskriv om du har någon smärta i den opererade höften? 
 
A. Ingen  
B. Lätt smärta, ingen begränsning i aktivitet, känner av höften vid enstaka tillfällen  
C. Lindrig, ej påverkan i dagliga aktiviteter, smärta vid större ansträngning, ibland 
smärtstillande läkemedel  
D. Måttlig smärta, begränsad i dagliga aktiviteter, regelbundet smärtstillande läkemedel  
E. Uttalad smärta, stark begränsning i dagliga aktiviteter, regelbundet starka smärtstillande 
läkemedel 
F. Invalidiserande smärta, vilosmärtor 
 
2. Använder du något gånghjälpmedel?  
A. Inget  
B. Käpp vid långa promenader  
C. Nästan alltid käpp  
D. 1 Krycka eller rollator  
E. 2 Käppar  
F. 2 Kryckor eller gångbord G. Går inte alls 
 
3. Har du hälta på den opererade sidan efter promenad med det gånghjälpmedel du 
använder? 
A. Ingen hälta  
B. Lätt hälta  
C. Måttlig hälta  
D. Uttalad hälta 
 
4. Hur långt kan du gå med det gånghjälpmedel du använder?  
A. Över 2 kilometer  
B. 1-2 kilometer  
C. 0,5 – 1 kilometer  
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D. Mindre än 0,5 kilometer eller endast inomhus  
E. Kan inte gå 
 
5. Trappor  
A. Jag går i trappa utan stöd  
B. Jag använder ledstång eller räcke vid trappgång  
C. Jag går i trappa med stora svårigheter  
E. Jag kan inte gå i trappa 
 
6. Ta på skor och strumpor på opererade sidan  
A. Utan svårighet  
B. Med svårighet  
C. Jag kan inte ta på mig skor och strumpor själv 
 
7. Sitta  
A. Jag kan sitta bekvämt på en vanlig stol  
B. Jag sitter endast bekvämt i en hög stol, jag kan endast sitta bekvämt i en halvtimme  
C. Jag kan inte sitta bekvämt i en halvtimme på grund av höftsmärta 
  
8. Tunnelbana/Buss  
A. Jag kan åka tunnelbana eller buss  
B. Jag kan inte åka tunnelbana eller buss 
 
Formulär EQ-5D 
Rörlighet 
1. Jag går utan svårigheter 
2. Jag kan gå men med viss svårighet 
3. Jag är sängliggande 
Hygien 
1. Jag behöver ingen hjälp med min dagliga hygien, mat eller påklädning 
2. Jag har vissa problem att tvätta eller klä mig själv 
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3. Jag kan inte tvätta eller klä mig själv 
Huvudsakliga aktiviteter (t ex arbete, studier, hushållssysslor, familje- och 
fritidsaktiviteter) 
1. Jag klarar av mina huvudsakliga aktiviteter 
2. Jag har vissa problem med att klara av mina huvudsakliga aktiviteter 
3. Jag klarar inte av mina huvudsakliga aktiviteter 
Smärtor/besvär 
1. Jag har varken smärtor eller besvär 
2. Jag har måttliga smärtor eller besvär 
3. Jag har svåra smärtor eller besvär 
Oro/nedstämdhet 
1. Jag är inte orolig eller nedstämd 
2. Jag är orolig eller nedstämd i viss utsträckning 
 
ADL 
• Oberoende i alla nedanstående funktioner 
•   Hjälp med bad/dusch 
•   Hjälp med påklädning 
•   Hjälp med toabesök 
•   Hjälp att komma i/ur säng 
•   Inkontinent 
•   Hjälp med att äta 
 
 
Smärt nummreringsskala (NRS)  
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Ringa in det nummer som bäst motsvarar din GENOMSNITTLIGA nivå för din 
höft/bensmärta i den opererade benet under de sju senaste dagarna  
1 – Ingen smärta  
2  
3  
4  
5  
6  
7  
8  
9  
10 – Värsta tänkbara smärta 
